The stock increased 1.41% or $0.06 on April 22, hitting $4.32. About 742 shares traded hands. First Trust ISE Glbl Pltnm Indx Fnd (NASDAQ:FTAG) has declined 32.66% since September 16, 2015 and is downtrending. It has underperformed by 37.48% the S&P500.

First Trust ISE Global Platinum Index Fund seeks investment results that correspond generally to the price and yield of the ISE Global Platinum Index (the Index). The company has a market cap of $4.74 million. The Fund will normally invest at least 90% of its net assets in securities that comprise the Index or in depositary receipts representing foreign securities in the Index. It currently has negative earnings. The Index is designed to provide a benchmark for investors interested in tracking public companies that are active in platinum group metals (PGM) mining based on revenue analysis of those companies.

The post First Trust Indxx Global Agriculture ETF Plans 1-for-5 Reverse Split (NASDAQ:FTAG) appeared first on Sonoran Weekly Review.

The stock decreased 31.14% or $0.52 during the last trading session, hitting $1.15. About 928,727 shares traded hands or 733.01% up from the average. FreeSeas Inc (NASDAQ:FREE) has declined 96.91% since September 16, 2015 and is downtrending. It has underperformed by 101.73% the S&P500.

FreeSeas Inc., through its subsidiaries, provides drybulk shipping services. Its vessels carry various drybulk commodities, such as iron ore, grain, and coal, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar, and rice.

Its fleet consists of five Handysize vessels and one Handymax vessel. As of April 23, 2015, its operational fleet had approximately 148,978 deadweight tons with the average age of 17.7 years. The company was formerly known as Adventure Holdings S.A. and changed its name to FreeSeas Inc. in April 2005. FreeSeas Inc. was founded in 2004 and is based in Athens, Greece.

The post FreeSeas Appeal to Nasdaq Listing Panel Denied, Stock to Trade OTC (NASDAQ:FREE) appeared first on Sonoran Weekly Review.

The stock recovered from late Thursday, when it plummeted following the release of FDA briefing documents, which implied the possibility that eteplirsen may not be approved. In the new draft questions, the FDA added several voting questions regarding the company’s application. Members of the committee were asked to vote whether the provided evidence were adequate and well controlled to prove that eteplirsen induces production of dystrophin to a level that is reasonably likely to predict clinical benefit. The FDA also asked the committee to consider whether there are identified or possible differences between the treatment and control groups, at baseline or during treatment, that may have had an impact on clinical course; whether the endpoints used to assess benefit were objective and assessed in a sufficiently similar way in the treatment and control groups to allow a valid comparison; and whether the reported effect size is large enough to conclude that the course of patients in Study 201/202 is clearly different from the usual course of patients with DMD. The Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee of the FDA will review the company’s NDA for eteplirsen on April 25, Monday. The Prescription Drug User Fee Act (PDUFA) action date for completion of FDA review of the eteplirsen is May 26.

The stock is up 2.21% or $0.33 after the news, hitting $15.28 per share. About 31.29 million shares traded hands or 761.98% up from the average. Sarepta Therapeutics Inc (NASDAQ:SRPT) has declined 70.44% since September 16, 2015 and is downtrending. It has underperformed by 75.26% the S&P500.

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. The companyÂ’s lead product candidate is Eteplirsen, an antisense phosphorodiamidate morpholino oligomer therapeutic, which is in Phase III clinical development for the treatment of individuals with Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease caused by the absence of dystrophin. It is also developing exon-skipping drugs for the treatment of DMD; and therapeutic candidates for the treatment of infectious diseases, such as influenza, Marburg, and Ebola. The company has a strategic alliance with CharleyÂ’s Fund, Inc. to support the development of product candidates using its proprietary exon-skipping technologies; and a license agreement with the University of Western Australia for the use of antisense sequences in the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

The post Sarepta Therapeutics Surges 36% Following Release of New FDA Draft Questions; Advisory Comittee Set to Meet on Monday to Discuss Eteplirsen NDA (NASDAQ:SRPT) appeared first on Sonoran Weekly Review.

The stock decreased 0.38% or $0.15 during the last trading session, hitting $39.7. About 101,395 shares traded hands. Empresa Nacional de Electricidad (ADR) (NYSE:EOC) has risen 7.15% since September 16, 2015 and is uptrending. It has outperformed by 2.33% the S&P500.

Empresa Nacional de Electricidad S.A., an electricity utility company, engages in the generation and transmission of electricity in Chile, Argentina, Brazil, Colombia, and Peru. The company generates electricity through hydroelectric, thermal, and wind power sources. As of December 31, 2014, it had 14,715 megawatts of installed capacity with 188 generation units.

The company supplies electricity to regulated electricity distribution companies; unregulated industrial firms primarily in the mining, pulp, and steel sectors; and pool market. It is also involved in the exploitation, generation, transmission, and distribution of natural gas; execution, construction, and exploitation of the El Melón tunnel; and provision of port administration and project engineering consulting services. The company was founded in 1943 and is headquartered in Santiago, Chile. Empresa Nacional de Electricidad S.A. operates as a subsidiary of Enersis Américas S.A.

The post Empresa Nacional de Electricidad Details Distribution of Shares of Endesa Americas in Relation to Spin-Off (NYSE:EOC) appeared first on Sonoran Weekly Review.

The stock increased 1.11% or $0.57 during the last trading session, hitting $51.77. About 1.21 million shares traded hands. Owens Corning (NYSE:OC) has risen 10.04% since September 16, 2015 and is uptrending. It has outperformed by 5.22% the S&P500.

Owens Corning, together with its subsidiaries, produces and sells glass fiber reinforcements and other materials for composites; and residential and commercial building materials worldwide. It operates in three segments: Composites, Insulation, and Roofing. The Composites segment manufactures, fabricates, and sells glass reinforcements in the form of fiber; and manufactures and sells glass fiber products in the form of fabrics, non-wovens, and other specialized products. Its products are used in pipe, roofing shingles, sporting goods, consumer electronics, telecommunications cables, boats, aviation, defense, automotive, industrial containers, and wind-energy applications in the building and construction, transportation, consumer, industrial, and power and energy markets.

The Insulation segment manufactures and sells fiberglass insulation into residential, commercial, industrial, and other markets for thermal and acoustical applications; and manufactures and sells glass fiber pipe insulation, flexible duct media, bonded and granulated mineral fiber insulation, and foam insulation used in above- and below-grade construction applications. It sells its products primarily to the insulation installers, home centers, lumberyards, retailers, and distributors. The Roofing segment manufactures and sells residential roofing shingles, oxidized asphalt materials, and roofing accessories used in residential and commercial construction, and specialty applications. This segment sells its products through home centers, lumberyards, retailers, distributors, and contractors, as well as to roofing contractors and distributors for built-up roofing asphalt systems and to manufacturers in automotive, chemical, rubber, and construction industries. Owens Corning was founded in 1938 and is headquartered in Toledo, Ohio.

The post Owens Corning Climbs 1.2% After Company Says $450 Mln InterWrap Acquisition Offers Growth Opportunities (NYSE:OC) appeared first on Sonoran Weekly Review.

The stock is down 0.50% or $0.01 after the news, hitting $1.99 per share. About 40,454 shares traded hands. API Technologies Corp (NASDAQ:ATNY) has declined 7.44% since September 16, 2015 and is downtrending. It has underperformed by 12.26% the S&P500.

API Technologies Corp., together with its subsidiaries, designs, develops, and manufactures systems, subsystems, modules, and components for radio frequency (RF) microwave, millimeterwave, electromagnetic, power, and security applications. It operates in three segments: Systems, Subsystems & Components (SSC); Electronic Manufacturing Services (EMS); and Secure Systems & Information Assurance (SSIA). The SSC segment offers RF, microwave, and millimeter wave; digital and mixed signal microcircuits, opto-electronic media conversion solutions, multi-chip modules, high temperature electronics, and power and general purpose hybrids and modules; electromagnetic integrated solutions; and power solutions.

The SSIA segment develops secure network and hardware solutions, including TEMPEST and emanation security, ruggedized systems, secure access, and information assurance products, as well as TEMPEST certification services under the EMCON, SST, Cryptek, ION, and Netgard brand names. The EMS segment provides new product introductions and prototypes, turnkey manufacturing, printed circuit board and electro-mechanical assembly, systems integration, test engineering, turnkey box build, and supply chain management services. The company primarily serves the defense, commercial and industrial, and non-defense government markets in the United States, the United Kingdom, Canada, China, Germany, and internationally. The company was formerly known as API Nanotronics Corp. and changed its name to API Technologies Corp. in October 2009. API Technologies Corp. was founded in 1993 and is based in Orlando, Florida.

The post API Technologies Announces Completion of Acquisition by Affiliate of J.F. Lehman, Requests Trading Suspension (NASDAQ:ATNY) appeared first on Sonoran Weekly Review.

U.S. Bancorp (NYSE:USB), the fifth-largest commercial bank in the U.S., and the parent company of Elavon, Inc., has sold its 50.1% majority stake in Sao Paulo-based, Elavon do Brasil to Stone Pagamentos, S.A, a local market, privately-held merchant acquirer.

Shares rose 1.7%. Financial terms of the agreement were not disclosed and the transaction will have no material impact on U.S. Bancorp, according to a statement Friday. Shares of US Bancorp trade near the top end of their 52-week range of $37.07 – $46.26.

The stock is up 0.01% or $0.01 after the news, hitting $43.3 per share. About 9.26M shares traded hands or 30.06% up from the average. U.S. Bancorp (NYSE:USB) has risen 0.47% since September 16, 2015 and is uptrending. It has underperformed by 4.35% the S&P500.

U.S. Bancorp, a financial services holding company, provides a range of financial services in the United States. It offers depository services, which include checking accounts, savings accounts, and time certificate contracts; and lending services, such as traditional credit products, as well as credit card services, leasing financing, import/export trade, asset-backed lending, agricultural finance, and other products. The company also provides ancillary services, including capital markets, treasury management, and receivable lock-box collection services to corporate customers; and a range of asset management and fiduciary services for individuals, estates, foundations, business corporations, and charitable organizations.

In addition, it offers investment and insurance products to the companyÂ’s customers principally within its markets, as well as fund administration services to a range of mutual and other funds. Further, the company provides corporate and purchasing card, and corporate trust services; and merchant processing services, as well as offers cash and investment management, ATM processing, mortgage banking, and brokerage and leasing services. It serves individuals, businesses, institutional organizations, governmental entities, and other financial institutions. The company offers its services through a network of 3,133 banking offices primarily in the Midwest and West regions of the United States; and a network of 4,936 ATMs, as well as through on-line services and over mobile devices. U.S. Bancorp was founded in 1863 and is headquartered in Minneapolis, Minnesota.

The post U.S. Bancorp Sells 50.1% Stake in Sao Paulo Unit Elavon do Brasil to Stone Pagamentos; Shares Rise 2% (NYSE:USB) appeared first on Sonoran Weekly Review.

The stock decreased 0.10% or $0.01 during the last trading session, hitting $9.88. About 190,588 shares traded hands. Renewable Energy Group Inc (NASDAQ:REGI) has risen 22.86% since September 16, 2015 and is uptrending. It has outperformed by 18.04% the S&P500.

Renewable Energy Group, Inc. produces and sells biofuels and renewable chemicals in the United States. It operates through Biomass-Based Diesel, Services, Renewable Chemicals, and Corporate and Other segments. The Biomass-Based Diesel segment acquires feedstock; manages, constructs, and operates biomass-based diesel production facilities; and markets, sells, and distributes biomass-based diesel and its co-products. This segment produces biomass-based diesel from a range of feedstocks, including inedible corn oil, used cooking oil, soybean oil, canola oil, and inedible animal fat.

It is also involved in purchase and resale of biomass-based diesel, petroleum-based diesel, renewable identification numbers, and raw material feedstocks acquired from third parties; and sale of glycerin, free fatty acids, naphtha, and other co-products of the biomass-based diesel production process. The Services segment provides facility management and operational services to biomass-based diesel production facilities, as well as to other clean-tech companies. This segment also offers construction management services for biomass-based diesel production facilities. The Renewable Chemicals segment engages in the production of renewable chemicals, advanced biofuels, and other products. The Corporate and Other segment trades petroleum-based heating oil and diesel fuel. Renewable Energy Group, Inc. was founded in 1996 and is headquartered in Ames, Iowa.

The post Renewable Energy Praises Extension of Biofuels Tax Incentives in Iowa (NASDAQ:REGI) appeared first on Sonoran Weekly Review.

The stock is up 16.67% or $0.055 after the news, hitting $0.385 per share. About 33,000 shares traded hands or 319.85% up from the average. bioMmune Technologies Inc (CVE:IMU) has risen 6.00% since March 23, 2016 and is uptrending. It has outperformed by 1.18% the S&P500.

bioMmune Technologies Inc. is a is a tier two research and development issuer. The company has a market cap of $11.58 million. The Firm is engaged in the research and development of products for the treatment of cancers and for improvement of the immune system. It currently has negative earnings.

The post TSXV-listed BioMmune Jumps 17% as Names Dr. Patrick Gray as New Chief Executive Officer and President (CVE:IMU) appeared first on Sonoran Weekly Review.

The stock is up 2.04% or $0.11 after the news, hitting $5.5 per share. About 23,485 shares traded hands. Datawatch Corporation (NASDAQ:DWCH) has declined 1.82% since September 16, 2015 and is downtrending. It has underperformed by 6.64% the S&P500.

Datawatch Corporation designs, develops, markets, and distributes business computer software products to self-service data preparation and visual data discovery markets in the United States and internationally. Its software solutions allow organizations to access, analyze, and visualize their information.

The companyÂ’s products include Datawatch Monarch, a self-service data preparation tool to explore, manipulate, and merge new data sources; Datawatch Designer that provides a range of specialized visualizations designed to make analyzing streaming data, time series data, and historical data; Datawatch Server to automate the data preparation process, manage and govern access, and visualize information from any data source; and Datawatch Report Mining Server, a Web-based report analytics solution that integrates with existing enterprise content management system for unlocking the corporate data. It also provides implementation and support of its software products, as well as training on their use and administration. The company sells its products to end-users through value-added resellers, strategic partners, and distributors. Datawatch Corporation was founded in 1985 and is headquartered in Chelmsford, Massachusetts.

The post Datawatch Strikes Agreement With Potrero Capital to Add Gillman to Board (NASDAQ:DWCH) appeared first on Sonoran Weekly Review.

The stock is down 5.30% or $0.41 after the news, hitting $7.33 per share. About 28,919 shares traded hands. Cipher Pharmaceuticals Inc (TSE:CPH) has risen 25.04% since September 21, 2015 and is uptrending. It has outperformed by 20.22% the S&P500.

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The company has a market cap of $189.86 million. The Firm has a portfolio of commercial and late-stage products. It has a 94.73 P/E ratio. It operates in the specialty pharmaceuticals segment.

The post Cipher Pharmaceuticals Announces Retirement Of CFO Norm Evans – Stock Falls 5% (TSE:CPH) appeared first on Sonoran Weekly Review.

The stock is 0.00% or $0 after the news, hitting $2.4 per share. It is down 70.00% since September 16, 2015 and is downtrending. It has underperformed by 74.82% the S&P500.

SkyPeople Fruit Juice, Inc., through its subsidiaries, produces and sells fruit juice concentrates, fruit beverages, and other fruit-related products in the PeopleÂ’s Republic of China and internationally. The company operates through six segments: Concentrated Apple Juice and Apple Aroma, Concentrated Kiwifruit Juice and Kiwifruit Puree, Concentrated Pear Juice, Fruit Juice Beverages, Fresh Fruits and Vegetables, and Others. It offers fruit juice concentrates, such as fruit purees, concentrated fruit purees, and concentrated fruit juices; concentrated apple, pear, and kiwifruit juices; pure fruit juice and fruit cider beverages, including apple juice, pear juice, kiwifruit juice, mulberry juice, kiwifruit cider, mulberry cider, peach juice, and pomegranate juice; and fresh fruits and vegetables, fructose, concentrated fruit and vegetable juices, and turnjujube juice, as well as other by products, such as kiwifruit seeds. The company sells its products directly to end-users; to hotels, supermarkets, and other outlets; and through trade Websites, as well as indirectly through distributors and agents. SkyPeople Fruit Juice, Inc. is headquartered in XiÂ’an, the PeopleÂ’s Republic of China.

The post SkyPeople Fruit Juice Up 3%, Says Intends to Submit Plan of Compliance to Nasdaq (NASDAQ:SPU) appeared first on Sonoran Weekly Review.

The stock is down 0.13% or $0.03 after the news, hitting $22.56 per share. About 38,080 shares traded hands. Spark Energy Inc (NASDAQ:SPKE) has risen 37.24% since September 16, 2015 and is uptrending. It has outperformed by 32.42% the S&P500.

Spark Energy, Inc., through its subsidiaries, operates as an independent retail energy services company in the United States. It operates through two segments, Retail Natural Gas and Retail Electricity. The company is involved in the retail distribution of natural gas and electricity to residential, commercial, and industrial customers. As of December 31, 2015, it operated in 66 utility service territories across 16 states, and had approximately 328,000 residential customers and 19,000 commercial customers. Spark Energy, Inc. was founded in 1999 and is headquartered in Houston, Texas.

The post Spark Energy Adds 1% – Crow Point Discloses 5.5% Stake (NASDAQ:SPKE) appeared first on Sonoran Weekly Review.

Apple (NASDAQ:AAPL) shares were slightly lower on Friday as The New York Times reported that the company’s iBooks Store and iTunes Movies were shut down in China. The report cited two people with knowledge of the matter as saying that the country’s State Administration of Press, Publication, Radio, Film and Television demanded the closings. NY Times cited a spokeswoman as saying the company hopes to make the services available again in China as soon as possible. AAPL trades in the lower half of the 52-week range between $92.00 and $134.54.

The stock is down 1.24% or $1.31 after the news, hitting $104.66 per share. About 18.60 million shares traded hands. Apple Inc. (NASDAQ:AAPL) has declined 8.97% since September 16, 2015 and is downtrending. It has underperformed by 13.79% the S&P500.

Apple Inc. designs, manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players to consumers, small and mid-sized businesses, education, and enterprise and government customers worldwide. The company also sells related software, services, accessories, networking solutions, and third-party digital content and applications. It offers iPhone, a line of smartphones; iPad, a line of multi-purpose tablets; and Mac, a line of desktop and portable personal computers. The company also provides iLife, a consumer-oriented digital lifestyle software application suite; iWork, an integrated productivity suite that helps users create, present, and publish documents, presentations, and spreadsheets; and other application software, such as Final Cut Pro, Logic Pro X, and FileMaker Pro.

In addition, it offers Apple TV that connects to consumersÂ’ TV and enables them to access digital content directly for streaming high definition video, playing music and games, and viewing photos; Apple Watch, a personal electronic device; and iPod, a line of portable digital music and media players. Further, the company sells Apple-branded and third-party Mac-compatible, and iOS-compatible accessories, such as headphones, displays, storage devices, Beats products, and other connectivity and computing products and supplies. Additionally, it offers iCloud, a cloud service; AppleCare that offers support options for its customers; and Apple Pay, a mobile payment service. The company sells and delivers digital content and applications through the iTunes Store, App Store, iBooks Store, Mac App Store, and Apple Music. It also sells its products through its retail and online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers, and value-added resellers. Apple Inc. was founded in 1977 and is headquartered in Cupertino, California.

The post Apple’s iBooks, iMovies Shut Down in China: New York Times (NASDAQ:AAPL) appeared first on Sonoran Weekly Review.

Microsoft (NASDAQ:MSFT) shares were lower nearly 9% on Friday as Re/code reported that the software giant and Google (GOOG) have reached an agreement to drop pending regulatory complaints against each other worldwide. The report cited a Microsoft representative as saying that the company agreed to withdraw its complaints, reflecting “changing legal priorities.” Google said in a statement that the company wants to compete “on the merits of our products, not in legal proceeds,” Re/code reported. MSFT trades in the upper half of the 52-week range between $39.72 and $56.85. GOOG was down nearly 6% at $733.48, in the upper half of the 52-week range between $532.23 and $810.35.

The stock is down 7.28% or $4.06 after the news, hitting $51.72 per share. About 84.26 million shares traded hands or 219.41% up from the average. Microsoft Corporation (NASDAQ:MSFT) has risen 25.91% since September 16, 2015 and is uptrending. It has outperformed by 21.09% the S&P500.

Microsoft Corporation, a technology company, develops, licenses, and supports software products, services, and devices worldwide. The companyÂ’s Devices and Consumer (D&C) Licensing segment licenses Windows operating system and related software; Microsoft Office for consumers; and Windows Phone operating system. Its Computing and Gaming Hardware segment provides Xbox gaming and entertainment consoles and accessories, second-party and third-party video games, and Xbox Live subscriptions; surface devices and accessories; and Microsoft PC accessories. The companyÂ’s Phone Hardware segment offers Lumia phones and other non-Lumia phones.

Its D&C Other segment provides Windows Store and Xbox marketplace; search advertising; display advertising; Office 365 Home and Office 365 Personal; first-party video games; and other consumer products and services, as well as operates retail stores. The companyÂ’s Commercial Licensing segments licenses server products, including Windows Server, Microsoft SQL Server, Visual Studio, System Center, and related Client Access Licenses (CALs); Windows Embedded; Windows operating system; Microsoft Office for business, such as Office, Exchange, SharePoint, and related CALs; Microsoft Dynamics business solutions; and Skype. Its Commercial Other segment offers enterprise services, including premier support services and Microsoft consulting services; commercial cloud comprising Office 365 Commercial, other Microsoft Office online offerings, Dynamics CRM Online, and Microsoft Azure; and other commercial products and online services. The company markets and distributes its products through original equipment manufacturers, distributors, and resellers, as well as through online and Microsoft retail stores. Microsoft Corporation was founded in 1975 and is based in Redmond, Washington.

The post Microsoft, Google to Drop Regulatory Complaints Against Each Other: Re/Code (NASDAQ:MSFT) appeared first on Sonoran Weekly Review.

The stock is up 0.15% or $0.06 after the news, hitting $39.63 per share. About 230,213 shares traded hands. Saputo Inc. (TSE:SAP) has risen 33.32% since September 16, 2015 and is uptrending. It has outperformed by 28.50% the S&P500.

Saputo Inc is a Canada-based dairy processor and cheese producer in the United States. The company has a market cap of $15.12 billion. Saputo produces, markets, and distributes a variety of dairy products, including cheese, fluid milk, extended shelf-life milk and cream products, cultured products and dairy ingredients. It has a 25.6 P/E ratio. The Company’s products are sold in 40 countries under brand names such as Saputo, Alexis de Portneuf, Armstrong, Baxter, Dairyland, Dragone, DuVillage 1860, Friendship, Frigo Cheese Heads, Great Midwest, King’s Choice, Kingsey, La Paulina, Milk2Go, Neilson, Nutrilait, Ricrem, Salemville, Scotsburn4, Stella, Sungold and Treasure Cave.

The post Saputo Says COO Dino Dello to Retire in April 2017; Stock Slips (TSE:SAP) appeared first on Sonoran Weekly Review.

NeuroDerm noted the FDA issued a warning letter to Cane in July 2015, requesting additional information regarding good manufacturing practices. The FDA has now determined that Cane’s corrective actions are deemed apparently adequate. NeuroDerm also said its clinical development plan remains on track both in the U.S. and the EU. NDRM was moving closer to the midpoint of the 52-week range of $11.38 to $26.50 in recent morning trade.

The stock is up 1.00% or $0.18 after the news, hitting $18.23 per share. About 53,172 shares traded hands. Neuroderm Ltd (NASDAQ:NDRM) has declined 18.80% since September 16, 2015 and is downtrending. It has underperformed by 23.62% the S&P500.

NeuroDerm Ltd., a clinical-stage pharmaceutical company, engages in developing products for the treatment of central nervous system (CNS) disorders. The companyÂ’s product candidates, which have completed Phase IIa clinical trial, include ND0612H for the treatment of patients with severe ParkinsonÂ’s disease; and ND0612L for the treatment of patients with moderate stage of Parkinson’s disease. It is also developing ND0801, which is in Phase IIa clinical trial for the treatment of cognition disorders associated with CNS diseases, such as ADD/ADHD, AlzheimerÂ’s disease, and schizophrenia; and ND0701, an apomorphine-based product candidate for the treatment of moderate to severe ParkinsonÂ’s disease. NeuroDerm Ltd. was founded in 2003 and is headquartered in Rehovot, Israel.

The post NeuroDerm Gains 1% – Reports Removal of FDA Import Alert on Third-Party Infusion Pumps (NASDAQ:NDRM) appeared first on Sonoran Weekly Review.

The stock is down 0.39% or $0.01 after the news, hitting $2.55 per share. About 93,718 shares traded hands. Bear Creek Mining Corp. (CVE:BCM) has risen 6.00% since March 23, 2016 and is uptrending. It has outperformed by 1.18% the S&P500.

Bear Creek Mining Corporation is engaged in the acquisition, exploration and development of precious and base metal properties located in Peru. The company has a market cap of $245.66 million. The Company’s development projects include Corani Silver-Lead-Zinc Project and Santa Ana Silver Project. It currently has negative earnings. The Company’s exploration projects include Maria Jose Prospect, La Yegua Copper-Gold-Molybdenum Prospect and Sumi Gold Prospect.

The post TSXV-listed Bear Creek Mining Board Approves Adoption of Shareholder Rights Plan; Shy of 52 Week Highs (CVE:BCM) appeared first on Sonoran Weekly Review.

He said the US and the world needs Britain’s “outsized influence to continue, including within Europe.” Obama attracted criticism from British politicians who are campaigning for an exit from the EU and saw his opinion piece as meddling. London Mayor Boris Johnson, a conservative politician, said Obama was hypocritical. “For the United States to tell us in the UK that we must surrender control of so much of our democracy, it is a breathtaking example of the principle of do as I say but not as I do,” Johnson wrote in the Sun newspaper. “It is incoherent. It is inconsistent, and yes it is downright hypocritical.

The Americans would never contemplate anything like the EU, for themselves or for their neighbors in their own hemisphere. Why should they think it right for us?” Obama is more popular in the UK than back home, with a 76% approval rating in Britain, compared with an about 50% rating in the US, measured in March, according to the Independent newspaper. While many polls are showing that the two sides are tied and the outcome remains too close to call, some suggested a shift in favor of remaining in the EU in recent days. The probability of Britain voting to leave the EU dropped to 20% on Thursday, according to the Number Cruncher Politics Referendum Forecast, which collates poll results. It stood at 24% on April 13, when the index was launched by political blogger Matt Singh. An ORB poll for the Daily Telegraph published on Tuesday suggested the ‘remain’ side leads the ‘leave’ camp 52% to 43%.

The stock closed at $3170 during the last session. It is down 6.00% since March 23, 2016 and is uptrending. It has outperformed by 1.18% the S&P500.

The post Obama Urges Britons to Stay in EU as ‘Leave’ Politicians Cry Hypocrisy (TYO:1347) appeared first on Sonoran Weekly Review.

Benz owners earlier this month filed a class-action lawsuit against Daimler saying the company’s BlueTec clean diesel system shuts off emission controls at certain speeds. Mercedes touts its models with BlueTec as “simply the world’s most advanced diesels, with the ultra-low emissions, high fuel economy and responsive performance that makes them not merely available in all 50 states, but desirable.” The company has come under fire, however, as the lawsuit alleges the company installed a product intended to defeat emissions tests in the US, similar to what Volkswagen admitted to doing last year. “The fact that Mercedes passed the dynamometer test in all tests, but failed the real world test, is suggestive that like VW, Mercedes is implementing a ‘defeat device’,” the lawsuit stated, according to several media outlets. Volkswagen this week agreed to fix or repurchase half a million diesel cars in the US equipped with the so-called defeat devices that allowed vehicles to emit 40 times legally allowed amounts of pollution. The company still has yet to hammer out a deal on how much it will pay in fines.

The stock is down 5.19% or EUR 3.43 after the news, hitting EUR 62.66 per share. Daimler AG (FRA:DAI) has 0.00% since September 24, 2015 and is . It has underperformed by 4.82% the S&P500.

Daimler AG is an automotive engineering company. The company has a market cap of 66.89 billion EUR. The Firm is engaged the development, production and distribution of cars, trucks and vans in Germany, and the management of the Daimler Group. It has a 7.96 P/E ratio. Mercedes-Benz Cars sells passenger cars and off-road vehicles under the Mercedes-Benz brand and small cars under the smart brand.

The post Daimler Begins Internal Review of Emissions at Department of Justice Request (FRA:DAI) appeared first on Sonoran Weekly Review.

Amazon.com (NASDAQ:AMZN) shares were slightly lower in recent pre-market trade as Bloomberg cited U.K.’s minister of state for transport Robert Goodwill as criticizing the electronic retailer for not providing guidance about the safe operation of drones to customers who buy these from the company. The report cited Goodwill as saying that Amazon has refused to include a government pamphlet that outlines British laws related to flying small unmanned aircraft safely, unlike other retailers including Maplin, Currys and Argos. Bloomberg cited the company as saying that U.K. customers are pointed to a section on the company’s web site for tips about responsible and safe flying. AMZN trades in the upper half of the 52-week range between $386.15 and $696.44.

The stock is down 1.30% or $8.2 after the news, hitting $622.8 per share. About 572,508 shares traded hands. Amazon.com, Inc. (NASDAQ:AMZN) has risen 19.65% since September 16, 2015 and is uptrending. It has outperformed by 14.83% the S&P500.

Amazon.com, Inc. engages in the retail sale of consumer products in North America and internationally. It operates through the North America, International, and Amazon Web Services (AWS) segments. The company sells merchandise and content purchased for resale from vendors, as well as those offered by third-party sellers through retail Websites, such as amazon.com, amazon.ca, amazon.com.mx, amazon.com.au, amazon.com.br, amazon.cn, amazon.fr, amazon.de, amazon.in, amazon.it, amazon.co.jp, amazon.nl, amazon.es, and amazon.co.uk. It also manufactures and sells electronic devices, including kindle e-readers, fire tablets, fire TVs, and echo, as well as fire phones; and provides Kindle Direct Publishing, an online platform that allows independent authors and publishers to make their books available in the Kindle Store.

In addition, the company offers programs that enable sellers to sell their products on its Websites, as well as their own branded Websites; and programs that allow authors, musicians, filmmakers, app developers, and others to publish and sell content. Further, it offers compute, storage, database, and other AWS services, as well as fulfillment, publishing, digital content subscriptions, advertising, and co-branded credit card agreements services. Additionally, the company offers Amazon Prime, an annual membership program, which provides free shipping of various items; access to unlimited streaming of movies and TV episodes; and other services. It serves consumers, sellers, developers, enterprises, and content creators. The company was founded in 1994 and is headquartered in Seattle, Washington.

The post Amazon.com Slips as UK Criticizes Co Over Lack of Drones Safety Guidance: Bloomberg (NASDAQ:AMZN) appeared first on Sonoran Weekly Review.

The stock is 0.00% or $0 after the news, hitting $5.05 per share. It is down 28.97% since September 16, 2015 and is downtrending. It has underperformed by 33.79% the S&P500.

Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). Its lead candidate is ARB-1467, a multi-component RNAi therapeutic product that is designed for the elimination of HBV surface antigen expression in patients chronically infected with HBV.

Its HBV product candidates also comprise ARB-1740, a RNAi HBV candidate that is in preclinical studies; small molecule cccDNA formation inhibitors for reducing the amount of cccDNA in the infected liver cell; HBV core protein assembly inhibitors; ARB-1598, a toll-like receptor; surface antigen secretion inhibitors; cccDNA epigenetic modifiers; stimulator of interferon genes agonists; and cyclophilin inhibitor drug candidates, including OCB-030 and other cyclophilin inhibitors. In addition, it develops TKM-PLK1, an oncology product platform that is in Phase I/II clinical trials for the treatment of gastrointestinal neuroendocrine tumors, adrenocortical carcinoma, and hepatocellular carcinoma; TKM-HTG, a multi-component RNAi therapeutic that targets a combination of genes expressed in the liver, which play a role in triglyceride metabolism; and TKM-ALDH, an aldehyde dehydrogenase to induce long term acute sensitivity to ethanol to treat severe alcohol use disorder. Further, its partnered programs consists of ALN-TTR02,whichis in Phase III clinical study, a therapeutic targeting transthyretin mediated amyloidosis; ALN-VSP for liver cancer; ALN-PCS02 for hypercholesterolemia; Marqibo for treating Philadelphia chromosome-negative acute lymphoblastic leukemia; and DCR-PH1 for primary hyperoxaluria type 1. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Burnaby, Canada.

The post Arbutus Biopharma Reports Positive Data from Studies of Hepatitis B Drug Candidates; Shares Steady Pre Bell (NASDAQ:ABUS) appeared first on Sonoran Weekly Review.

Visa (NYSE:V) shares were lower over 3% in recent pre-market trade after the company said that it has agreed with Visa Europe to amend the deal to eliminate the earn-out portion of the transaction consideration in response to feedback from the European Commission. The payment technology company said that instead of an earn-out the cash consideration in the deal will be increased by EUR1.75 billion ($1.98 billion), of which EUR750 million is payable upon closing and EUR1 billion, plus 4% compound annual interest, payable on the third anniversary of closing. Visa noted that while the parties are working to close as soon as possible, closing could extend beyond the end fiscal Q3. V trades near the top end of the 52-week range between $60.00 and $81.73.

The stock increased 0.05% or $0.04 during the last trading session, hitting $80.83. About 68,872 shares traded hands. Visa Inc (NYSE:V) has risen 13.80% since September 16, 2015 and is uptrending. It has outperformed by 8.98% the S&P500.

Visa Inc., a payments technology company, operates an open-loop payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants.

The company also provides a suite of digital, ecommerce, person-to-person payments, and mobile products and services. In addition, it offers merchant gateway services for ecommerce merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. The company provides its services under the Visa, Visa Electron, Interlink, and PLUS brands. Visa Inc. has a strategic alliance with Bottomline Technologies. The company was incorporated in 2007 and is headquartered in San Francisco, California.

The post Visa Shares Slip 3%; Eliminates Earn-Out Portion of Visa Europe Deal Consideration (NYSE:V) appeared first on Sonoran Weekly Review.

The stock closed at $0.105 during the last session. It is down 6.00% since March 23, 2016 and is uptrending. It has outperformed by 1.18% the S&P500.

Salazar Resources Limited is Canada is a mineral resource company. The company has a market cap of $7.37 million. The Company’s principal business activity is the acquisition, exploration and development of mineral properties in Ecuador and Colombia. It currently has negative earnings. The Firm has no proven or probable reserves.

The post TSXV-Listed Salazar Resources Delays Closing of Proposed US$1 Mln Financing (CVE:SRL) appeared first on Sonoran Weekly Review.

The stock decreased 26.36% or $9.71 during the last trading session, hitting $27.12. About 68,884 shares traded hands. Intrexon Corp (NYSE:XON) has declined 41.48% since September 16, 2015 and is downtrending. It has underperformed by 46.30% the S&P500.

Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; RheoSwitch inducible gene switch; Cell Systems Informatics; AttSite Recombinases; Protein Engineering; antibody discovery; LEAP processing; and ActoBiotics platform.

It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; biological insect control solutions; technologies for non-browning apple without the use of any flavor altering chemical or antioxidant additives; and commercial aquaculture products. The company serves health, food, energy, environment, and consumer sectors. Intrexon Corporation has collaboration and license agreements with Ares Trading S.A.; ZIOPHARM Oncology, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; S & I Ophthalmic, LLC; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Thrive Agrobiotics, Inc.; Intrexon Energy Partners II, LLC; and others. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.

The post Intrexon Says Share Price Plunge Result of Attempted Manipulation By Short Sellers; Claims “Inaccurate” (NYSE:XON) appeared first on Sonoran Weekly Review.

The stock decreased 27.70% or $0.058 on April 21, hitting $0.151. Aeropostale Inc (NYSE:ARO) has declined 81.71% since September 16, 2015 and is downtrending. It has underperformed by 86.53% the S&P500.

Aéropostale, Inc. operates as a specialty retailer of casual apparel and accessories for 14 to 17 year-old young women and men. It operates through two segments, Retail Stores and E-Commerce, and International Licensing. The company also offers casual clothing and accessories focusing on kids between the ages of 4 to 12 year olds. As of October 21, 2015, it operated 758 Aéropostale stores in 50 states and Puerto Rico, 41 Aéropostale stores in Canada, and 25 P.S. from Aéropostale stores in 12 states.

In addition, the company markets its products through ps4u.com and aeropostale.com, as well as its licensees operate 297 Aéropostale and P.S. from Aéropostale locations in the Middle East, Asia, Europe, and Latin America under various licensing agreements. Further, it operates GoJane.com that retails in fashion footwear, contemporary apparel, and other accessories for women online. Aéropostale, Inc. has a strategic partnership with Sycamore Partners. The company was formerly known as MSS-Delaware, Inc. and changed its name to Aéropostale, Inc. in February 2000. Aéropostale, Inc. was founded in 1987 and is headquartered in New York, New York.

The post Aeropostale Trading Suspended On NYSE; Common Stock To Trade On OTCQX Market Under Ticker AROP (NYSE:ARO) appeared first on Sonoran Weekly Review.

The stock increased 3.66% or $0.6 during the last trading session, hitting $17.01. Applied Genetic Technologies Corp (NASDAQ:AGTC) has risen 14.70% since September 16, 2015 and is uptrending. It has outperformed by 9.88% the S&P500.

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products to treat patients with severe inherited orphan diseases in ophthalmology in the United States. The companyÂ’s lead product candidates include treatments for X-linked retinoschisis, achromatopsia, and X-linked retinitis pigmentosa, which are inherited orphan diseases of the eye caused by mutations in single genes.

It is also developing adeno-associated virus based gene therapies for the treatment of rare eye diseases; and a product candidate for treatment of alpha-1 antitrypsin deficiency for which it has conducted preclinical proof-of-concept studies and Phase I and Phase II clinical trials. In addition, the company is involved in the pre-clinical development of treatments for wet age-related macular degeneration. Applied Genetic Technologies Corporation has collaboration agreements with Biogen; and 4D Molecular Therapeutics. The company was founded in 1999 and is headquartered in Alachua, Florida.

The post Applied Genetic Technologies Reports Encouraging Data for Retinal Disease Treatment; Shares Flat Pre Bell (NASDAQ:AGTC) appeared first on Sonoran Weekly Review.

The Wall Street Journal also reported that Valeant was looking to name Papa as next CEO. Valeant said in March CEO Michael Pearson was leaving the company, just three weeks after returning from a two-month medical leave. Pearson said he would remain in the position until a successor is found. Valeant declined to comment on the Papa appointment.

The stock increased 0.07% or $0.03 on April 21, hitting $42.47. About 868,646 shares traded hands. Valeant Pharmaceuticals Intl Inc (TSE:VRX) has declined 86.18% since September 16, 2015 and is downtrending. It has underperformed by 91.00% the S&P500.

Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The company has a market cap of $14.50 billion. The Firm is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over 100 countries. It currently has negative earnings. The Firm operates through two divisions: developed markets and emerging markets.

The post Valeant Pharmaceuticals Set to Name New CEO: Reports (TSE:VRX) appeared first on Sonoran Weekly Review.

The stock decreased 3.76% or $0.48 during the last trading session, hitting $12.3. Cameco Corporation (USA) (NYSE:CCJ) has declined 12.02% since September 16, 2015 and is downtrending. It has underperformed by 16.84% the S&P500.

Cameco Corporation produces and sells uranium worldwide. It operates through three segments: Uranium, Fuel Services, and NUKEM. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrates. Its operating uranium properties include the McArthur River/Key Lake, Cigar Lake, and Rabbit Lake properties located in Saskatchewan, Canada; the Inkai property situated in Kazakhstan; and the Smith Ranch-Highland property located in Wyoming, as well as the Crow Butte property situated in Nebraska, the United States.

The Fuel Services segment provides refining, conversion, and uranium fuel manufacturing services. Its products include uranium trioxide, uranium hexafluoride, and uranium dioxide. This segment also manufactures and sells fuel bundles and reactor components for CANDU reactors. The NUKEM segment trades in uranium and uranium-related products. The company sells its uranium and fuel services to nuclear utilities. Cameco Corporation was founded in 1987 and is headquartered in Saskatoon, Canada.

The post Cameco Halts Saskatchewan Operations, Postpones Wellfield Development (NYSE:CCJ) appeared first on Sonoran Weekly Review.

The stock decreased 7.41% or $0.04 on April 21, hitting $0.5. Real Goods Solar, Inc. – Class A (NASDAQ:RGSE) has declined 63.24% since September 16, 2015 and is downtrending. It has underperformed by 68.06% the S&P500.

Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It operates in three segments: Residential, Sunetric, and Other.

The company offers solar energy services, including design, procurement, permitting, build-out, grid connection, financing referrals, and warranty and customer satisfaction. It installs residential solar energy systems up to 15 kilowatts (kW) in size; and small commercial solar energy systems up to 500 kW in size for various industries, such as retail, manufacturing, service, and municipal services. The company markets its products and services through an outside sales team, e-sales, and inside sales, customer referral programs, and alliances and channel partnerships, as well as online. Real Goods Solar, Inc. was founded in 1978 and is headquartered in Louisville, Colorado.

The post Real Goods Solar Seeks Shareholder Approval For Up to 1-For-20 Reverse Stock Split (NASDAQ:RGSE) appeared first on Sonoran Weekly Review.

After resuming trade, SUNE was flat at $0.34, in a 52-week range of $0.20 to $33.45. SunEdison’s two publicly-traded yieldcos noted they are not part of the SunEdison bankruptcy filing and said they believe to have enough liquidity to operate their businesses. Although SunEdison’s bankruptcy presents challenges, TerraForm Power and TerraForm Global said they expect to continue to operate in ordinary course and meet their financial obligations on a timely basis.

In addition, the two companies said they plan to coordinate with SunEdison so that their facilities and operations continue to perform uninterrupted. Earlier Thursday, SunEdison company noted TerraForm Power and TerraForm Global are not part of the filing. SunEdison said it secured $300 million in new debtor-in-possession financing from a consortium of first and second lien lenders. The new capital, which is subject to court approval, will be used by the company to support its continuing business operations, minimize disruption to its worldwide projects and partnerships, and make necessary operational changes. SunEdison CEO Ahmad Chatila said, “The court process will allow us to right-size our balance sheet and reduce our debt, providing the opportunity to support the business going forward while focusing on our core strengths. It also will facilitate our continued work towards transforming the company into a more streamlined and efficient operator, shedding non-core assets as well as taking other steps to help us get the most value out of our technological and intellectual property.

The stock increased 0.56% or $0.002 on April 21, hitting $0.34. About 4.54 million shares traded hands. Sunedison Inc (NYSE:SUNE) has declined 97.04% since September 16, 2015 and is downtrending. It has underperformed by 103.33% the S&P500.

SunEdison, Inc., a renewable energy development company, develops, finances, installs, owns, and operates renewable power plants to residential, commercial, government, and utility customers. It operates through Renewable Energy Development, TerraForm Power, and TerraForm Global segments. The Renewable Energy Development segment provides renewable energy services that integrate the design, installation, financing, monitoring, operations, and maintenance portions of the renewable energy industry segment.

It also owns and operates renewable energy power plants; manufactures polysilicon and silicon wafers; and subcontracts the assembly of solar modules to support downstream solar business, as well as for sale to external customers as market conditions dictate. The TerraForm Power segment owns and operates clean power generation assets that sell electricity through long-term PPAs to utility, commercial, and residential customers based in Organization for Economic Co-operation and Development (OECD) member countries, such as the United States, the United Kingdom, Canada, and Chile. The TerraForm Global segment owns and operates clean power generation assets that sell electricity through long-term PPAs to utility and commercial customers based in specified emerging market countries located in Asia, Africa, Latin America, and the Middle East. The company was formerly known as MEMC Electronic Materials, Inc. and changed its name to SunEdison, Inc. in May 2013. SunEdison, Inc. was founded in 1984 and is headquartered in Maryland Heights, Missouri.

The post TerraForm Power, TerraForm Global Have No Plans to File For Bankruptcy Despite SunEdison’s Chapter 11 Reorganization (NYSE:SUNE) appeared first on Sonoran Weekly Review.

These banks include Commerzbank AG, Amro Group NV and Societe Generale SA., the report stated further. The U.S. Justice Department is also sifting through the leaked files for any evidence of corruption and violations of U.S. laws, Reuters said further. Reuters said it has reached out to spokespersons from Deutsche Bank and Credit Suisse but they declined to comment, while people from the other banks could not be reached immediately. DB shares were down 0.1% at $18.70, with a 52-week range of $14.78 – $35.38; CS shares were down 1.4% at $15.60, with a 52-week range of $12.56 – $29.99.

The stock decreased 0.19% or $0.03 during the last trading session, hitting $18.68. About 4.38 million shares traded hands or 13.18% up from the average. Deutsche Bank AG (USA) (NYSE:DB) has declined 36.82% since September 15, 2015 and is downtrending. It has underperformed by 43.11% the S&P500.

Deutsche Bank AG provides investment, financial, and related products and services worldwide. The company operates through Global Markets; Corporate & Investment Banking; Private, Wealth and Commercial Clients; Postbank, Deutsche Asset Management; and Non-Core Operations Unit segments.

It offers a range of financial marketsÂ’ products, including bonds, equities and equity-linked products, exchange-traded and over-the-counter derivatives, foreign exchange, money market instruments, and securitized products, as well as mergers and acquisitions, and debt and equity advisory and origination services; and commercial banking, advisory banking, and financial services. The company also provides investment and insurance, mortgages, business products, consumer finance, payments, cards and accounts, deposits, and mid-cap related products, as well as life and non-life insurance products, and corporate pension schemes; payments, financing for international trade, lending, trust, agency, depositary, custody, and related services; invests in a range of asset classes, including equities, fixed income, real estate, infrastructure, private equity, and hedge funds; and offers customized wealth management solutions and private banking services, such as lending and discretionary portfolio management. As of December 31, 2015, it operated 2,790 branches in 70 countries. Deutsche Bank AG was founded in 1870 and is headquartered in Frankfurt am Main, Germany.

The post Deutsche Bank, Credit Suisse Ordered to Hand Over Records of Dealings with Panama Law Firm in Connection to “Panama Papers” Investigation: Reuters (NYSE:DB) appeared first on Sonoran Weekly Review.

The stock increased 2.34% or $0.86 on April 21, hitting $37.68. About 1.24 million shares traded hands or 21.57% up from the average. Pembina Pipeline Corp (TSE:PPL) has risen 10.85% since September 15, 2015 and is uptrending. It has outperformed by 4.57% the S&P500.

Pembina Pipeline Corporation is an energy transportation and service provider. The company has a market cap of $14.40 billion. The Firm operates through four divisions: Conventional Pipelines, Oil Sands & Heavy Oil, Gas Services and Midstream. It has a 36.82 P/E ratio. Conventional Pipelines consists of the tariff activities of pipelines and related facilities to deliver crude oil, condensate and natural gas liquids (NGL) in Alberta, British Columbia, Saskatchewan, and North Dakota, United States.

The post Pembina Pipeline Receives Go-Ahead For Fox Creek Phase III Expansion (TSE:PPL) appeared first on Sonoran Weekly Review.

ESI said it strongly believes the facts it provides in response to ACICS’s request will continue to demonstrate the company’s compliance with regulatory and accreditation criteria. The company says it is confident it has and will continue to meet the ACICS accreditation standards. Volume was heavy at more than 1.7 million shares. Average three-month daily volume is just more than 278,000.

The stock decreased 11.43% or $0.32 on April 21, hitting $2.48. About 2.01M shares traded hands or 441.68% up from the average. ITT Educational Services, Inc. (NYSE:ESI) has declined 22.87% since September 15, 2015 and is downtrending. It has underperformed by 29.15% the S&P500.

ITT Educational Services, Inc. provides postsecondary degree programs in the United States. It offers master, bachelor, and associate degree programs to approximately 45,000 students; and short-term information technology and business learning solutions for career advancers and other professionals. The companyÂ’s business education programs include accounting, business administration, financial services, manufacturing, marketing and advertising, and sales; and drafting and design programs consist of architectural and construction drafting, civil drafting, computer aided drafting, electrical and electronics drafting, industrial engineering technology, interior design, landscape architecture, mechanical drafting, and multimedia communications.

Its electronics technology programs include communications, computer technology, electronics product design and fabrication, industrial electronics, instrumentation, and telecommunications; and criminal justice programs include corrections, cyber security, investigations, and security and policing. The companyÂ’s IT programs include communications, network administration, network technology, software development, systems technology, and technical support; and Breckinridge school of nursing and health sciences programs comprise health information technology, medical assisting and administration, and nursing. As of December 31, 2015, it had 138 college locations in 39 states. The company was founded in 1946 and is headquartered in Carmel, Indiana.

The post ITT Educational Services Tumbles 12.5% in Heavy Volume After ACICS Questions Co’s Financial Viability, Inegrity and Ability to Serve Students In Accordance to Standards (NYSE:ESI) appeared first on Sonoran Weekly Review.

Investigations conducted by the Ontario Provincial Police and the Ministry of Labour have been ongoing since the Company’s news release of September 2, 2015 and continue. The Company understands that the Ministry of Labour has until June 2016 to conclude its investigation and therefore additional regulatory charges under the Occupational Health and Safety Act may still be brought in relation to this incident. “We have and will continue to cooperate fully with both the Ontario Provincial Police and Ministry of Labour throughout their investigations and are taking these charges very seriously. We now need to obtain the information on which the charges have been brought in order to be in a position to comment further. In the meantime, we would like to express our sincere condolences to the family,” stated Paul Martin, President and CEO of Detour Gold.

The stock increased 1.41% or $0.35 on April 21, hitting $25.26. About 1.84 million shares traded hands or 31.43% up from the average. Detour Gold Corporation (TSE:DGC) has risen 58.99% since August 31, 2015 and is uptrending. It has outperformed by 52.71% the S&P500.

Detour Gold Corporation is a Canada intermediate gold producing company. The company has a market cap of $4.38 billion. The Firm is engaged in the acquisition, exploration, development and operation of mineral property interests. It currently has negative earnings. The Company’s primary asset is its Detour Lake mine, which is an open pit operation located in northeastern Ontario, approximately 300 kilometers northeast of Timmins and over 180 kilometers by road northeast of Cochrane.

The post Detour Gold Charged With Criminal Negligence Over June 2015 Mine Fatality (TSE:DGC) appeared first on Sonoran Weekly Review.

The stock decreased 27.70% or $0.058 on April 21, hitting $0.151. About 6.20 million shares traded hands or 133.08% up from the average. Aeropostale Inc (NYSE:ARO) has declined 73.42% since September 15, 2015 and is downtrending. It has underperformed by 79.70% the S&P500.

Aéropostale, Inc. operates as a specialty retailer of casual apparel and accessories for 14 to 17 year-old young women and men. It operates through two segments, Retail Stores and E-Commerce, and International Licensing. The company also offers casual clothing and accessories focusing on kids between the ages of 4 to 12 year olds. As of October 21, 2015, it operated 758 Aéropostale stores in 50 states and Puerto Rico, 41 Aéropostale stores in Canada, and 25 P.S. from Aéropostale stores in 12 states.

In addition, the company markets its products through ps4u.com and aeropostale.com, as well as its licensees operate 297 Aéropostale and P.S. from Aéropostale locations in the Middle East, Asia, Europe, and Latin America under various licensing agreements. Further, it operates GoJane.com that retails in fashion footwear, contemporary apparel, and other accessories for women online. Aéropostale, Inc. has a strategic partnership with Sycamore Partners. The company was formerly known as MSS-Delaware, Inc. and changed its name to Aéropostale, Inc. in February 2000. Aéropostale, Inc. was founded in 1987 and is headquartered in New York, New York.

The post Aeropostale Plummets to New Low; Said to Prepare For Bankruptcy: Bloomberg (NYSE:ARO) appeared first on Sonoran Weekly Review.

The stock increased 13.33% or $0.01 on April 21, hitting $0.085. About 519,051 shares traded hands or 410.03% up from the average. Corex Gold Corporation (CVE:CGE) has risen 6.00% since March 23, 2016 and is uptrending. It has underperformed by 0.28% the S&P500.

Corex Gold Corporation is an exploration-stage company. The company has a market cap of $6.85 million. The Firm is primarily engaged in the acquisition and exploration of precious metal properties located in Mexico. It currently has negative earnings. The Company’s primary focus is the exploration and development of its Santana Project, which is a discovery in Sonora Mexico.

The post TSXV-Listed Corex Gold Hilts 4-Year High After Granted Mining Permit For Santana Project (CVE:CGE) appeared first on Sonoran Weekly Review.

The stock decreased 1.78% or $0.07 on April 21, hitting $3.87. About 521,610 shares traded hands. VimpelCom Ltd (ADR) (NASDAQ:VIP) has declined 19.43% since September 15, 2015 and is downtrending. It has underperformed by 25.71% the S&P500.

VimpelCom Ltd. provides mobile telecommunications services in Russia, Algeria, Pakistan, Bangladesh, Ukraine, Kazakhstan, Uzbekistan, Tajikistan, Italy, Armenia, Georgia, Kyrgyzstan, and Laos. It offers voice, data, and other telecommunication services through a range of traditional and broadband mobile and fixed line technologies. The company offers mobile telecommunications services under contract and prepaid plans for both corporate and consumer segments; value added services, including messaging services, content/infotainment services, data access services, location based services, media, and content delivery channels; national and international roaming services; wireless Internet access; mobile financial services; and mobile bundles. It also provides fixed-line telecommunication services, such as voice, data, and Internet services to corporations, operators, and consumers.

In addition, the company sells equipment and accessories; provides specialized customer care services; and offers other data services, such as machine-to-machine, mobile virtual private network, geo-positioning services, fixed mobile convergence, and mobile cloud solutions. As of December 31, 2015, VimpelCom Ltd. owned 1,455 retail mono-brand stores. It offers its services under the Beeline, Kyivstar, banglalink, Mobilink, Djezzy, and Infostrada brands. As of December 31, 2015, the company served approximately 217.4 million mobile customers in 14 countries. VimpelCom Ltd. was founded in 1992 and is headquartered in Amsterdam, the Netherlands.

The post VimpelCom Slips 2% – EU Officials Extend Probe on Italian Deal with CK Hutchison: Reuters (NASDAQ:VIP) appeared first on Sonoran Weekly Review.

The stock closed at $0.05 during the last session. It is up 6.00% since March 23, 2016 and is uptrending. It has underperformed by 0.28% the S&P500.

The post TSXV-Listed Horizon Petroleum to Acquire Private Calgary Corp, Announces Private Placement, Name Change to Scion Energy (CVE:HPL) appeared first on Sonoran Weekly Review.

Approximately 1,000 direct and indirect employees and contractors have been affected by the disruption, the miner noted. Aura said it is confident that a resolution will be forthcoming as it works with all parties to peacefully resolve the situation. This isn’t the first time operations have been disrupted at San Andres. A similar occupation took place in November of last year, according to Reuters. ORA shares were recently down 12% at $0.220 apiece.

The stock decreased 12.00% or $0.03 on April 21, hitting $0.22. About 683,850 shares traded hands or 323.73% up from the average. Aura Minerals Inc. (TSE:ORA) has risen 257.14% since September 15, 2015 and is uptrending. It has outperformed by 250.86% the S&P500.

Aura Minerals Inc. is a Canada gold‐copper production firm focused on the operation and development of gold and copper projects in the Americas. The company has a market cap of $58.20 million. The Company’s assets include The San Andres Gold Mine (San Andres), The Sao Francisco Gold Mine (Sao Francisco), The Aranzazu Copper Mine (Aranzazu) and The Serrote da Laje Project (Serrote). It currently has negative earnings. The Firm owns a 100% interest in San Andres mine, an open‐pit heap leach gold mine located in the highlands of western Honduras.

The post Aura Minerals Suspends Operations at San Andres Mine in Honduras Following Occupation by Local Community – Shares Crash 12% (TSE:ORA) appeared first on Sonoran Weekly Review.

Shares of Apple Inc. (NASDAQ:AAPL) were inching lower Thursday morning after the company said it would unveil Q2 financial results on April 26 after the market closes. According to the Nasdaq website, the technology giant was slated to report Q2 results on April 25. Apple said it rescheduled the earnings release due to a memorial service to be held for technology-industry advisor Bill Campbell on April 25. AAPL was down less than 1% in recent trade, moving in the lower half of the 52-week range of $92.00 to $134.54.

The stock is down 0.41% or $0.43 after the news, hitting $105.54 per share. About 31.24 million shares traded hands. Apple Inc. (NASDAQ:AAPL) has declined 7.87% since September 15, 2015 and is downtrending. It has underperformed by 14.15% the S&P500.

Apple Inc. designs, manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players to consumers, small and mid-sized businesses, education, and enterprise and government customers worldwide. The company also sells related software, services, accessories, networking solutions, and third-party digital content and applications. It offers iPhone, a line of smartphones; iPad, a line of multi-purpose tablets; and Mac, a line of desktop and portable personal computers. The company also provides iLife, a consumer-oriented digital lifestyle software application suite; iWork, an integrated productivity suite that helps users create, present, and publish documents, presentations, and spreadsheets; and other application software, such as Final Cut Pro, Logic Pro X, and FileMaker Pro.

In addition, it offers Apple TV that connects to consumersÂ’ TV and enables them to access digital content directly for streaming high definition video, playing music and games, and viewing photos; Apple Watch, a personal electronic device; and iPod, a line of portable digital music and media players. Further, the company sells Apple-branded and third-party Mac-compatible, and iOS-compatible accessories, such as headphones, displays, storage devices, Beats products, and other connectivity and computing products and supplies. Additionally, it offers iCloud, a cloud service; AppleCare that offers support options for its customers; and Apple Pay, a mobile payment service. The company sells and delivers digital content and applications through the iTunes Store, App Store, iBooks Store, Mac App Store, and Apple Music. It also sells its products through its retail and online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers, and value-added resellers. Apple Inc. was founded in 1977 and is headquartered in Cupertino, California.

The post Apple Delays Q2 Earnings Release By One Day to April 25 – Shares Slip 0.7% (NASDAQ:AAPL) appeared first on Sonoran Weekly Review.

The stock is down 0.14% or $0.05 after the news, hitting $35 per share. About 2.80 million shares traded hands or 91.78% up from the average. Iron Mountain Inc (NYSE:IRM) has risen 21.32% since September 15, 2015 and is uptrending. It has outperformed by 15.04% the S&P500.

Iron Mountain Incorporated, together with its subsidiaries, provides storage and information management services in North America, Europe, Latin America, and the Asia Pacific. It operates through North American Records and Information Management Business, North American Data Management Business, Western European Business, and Other International Business segments. The company provides storage and information management services for physical records and other media, such as microfilm and microfiche, master audio and videotapes, film, X-rays, and blueprints, including healthcare information services, vital records services, and service and courier operations, as well as the collection, handling, disposal of sensitive documents for corporate customers.

It also offers information destruction services primarily consist of physical secure shredding operations; document management solutions to develop, implement, and support storage and information management solutions for the complete lifecycle of its customers’ information; fulfillment services; technology escrow services that protect and manage source code; and professional consulting services, as well as sells resultant waste paper to third-party recyclers. In addition, the company is involved in the storage and rotation of backup computer media operations, including records management, data protection and recovery, server and computer backup services, and digital content repository systems to house, distribute, and archive key media assets, as well as for storage, safeguarding, and electronic or physical delivery of physical media primarily for the entertainment and media industry clients. It serves commercial, legal, banking, healthcare, accounting, insurance, entertainment, and government organizations. Iron Mountain Incorporated was founded in 1951 and is headquartered in Boston, Massachusetts.

The post Iron Mountain Gets Australian Court OK For Recall Acquisition (NYSE:IRM) appeared first on Sonoran Weekly Review.

The stock is down 0.26% or $0.07 after the news, hitting $26.71 per share. About 3,676 shares traded hands. Handy & Harman Ltd (NASDAQ:HNH) has risen 7.64% since September 15, 2015 and is uptrending. It has outperformed by 1.35% the S&P500.

Handy & Harman Ltd. manufactures and sells engineered niche industrial products. It operates through Joining Materials, Tubing, Building Materials, Performance Materials, and Kasco Blades and Route Repair Services segments. The Joining Materials segment fabricates precious metals and their alloys into brazing alloys, including gold, silver, palladium, copper, nickel, aluminum, and tin for use in electrical, appliance, transportation, construction, and general industrial industries. The Tubing segment provides seamless stainless steel tubing coils for petrochemical infrastructure and shipbuilding markets; small diameter coil tubing to the aerospace, defense, and semiconductor fabrication markets; and welded carbon steel tubing products in coiled and straight lengths for transportation, appliance and heating, and oil and gas industries.

The Building Materials segment offers fasteners and fastening systems for the commercial low slope roofing industry; and engineered specialty fasteners for the building products industry. The Performance Materials segment manufactures sheet and mechanically formed glass and aramid materials for specialty applications. The Kasco Blades and Route Repair Services segment provides meat-room blade products, repair services, and resale products for the meat and deli departments of supermarkets, restaurants, and meat and fish processing plants, as well as for distributors of electrical saws and cutting equipment; and wood cutting blade products for the pallet manufacturing, pallet recycler, and portable saw mill industries. The company sells its products and services through direct sales forces, distributors, and manufacturerÂ’s representatives to the construction, electrical, electronics, transportation, utility, medical, oil and gas exploration, aerospace and defense, and food industries in North and South America, Europe, Australia, Asia, and internationally. Handy & Harman Ltd. was founded in 1852 and is based in White Plains, New York.

The post Handy & Harman Starts Tender Offer For SL Industries (NASDAQ:HNH) appeared first on Sonoran Weekly Review.

The stock is down 2.86% or $0.04 after the news, hitting $1.36 per share. About 14,262 shares traded hands. General Steel Holdings Inc (NYSE:GSI) has declined 55.56% since September 15, 2015 and is downtrending. It has underperformed by 61.84% the S&P500.

General Steel Holdings, Inc., through its subsidiaries, manufactures and sells steel products in the PeopleÂ’s Republic of China. It offers hot-rolled carbon and silicon steel sheets under the Qiu Steel name; and reinforced bars and high-speed wires for infrastructure and construction applications under the Yu Long and Heng Da names, as well as spiral-weld pipes. The company sells its products primarily to distributors and related parties. General Steel Holdings, Inc. is headquartered in Beijing, China.

The post General Steel Gets Notice of Non-Compliance With NYSE Continued Listing Standards (NYSE:GSI) appeared first on Sonoran Weekly Review.

The stock is down 6.53% or $1.09 after the news, hitting $15.61 per share. About 905,102 shares traded hands or 32.85% up from the average. CARBO Ceramics Inc. (NYSE:CRR) has declined 23.60% since September 15, 2015 and is downtrending. It has underperformed by 29.89% the S&P500.

CARBO Ceramics Inc., an oilfield services technology company, manufactures and sells ceramic proppants, resin-coated ceramic, and resin-coated sand proppants for use in the hydraulic fracturing of natural gas and oil wells in the United States and internationally. The company offers ceramic proppants, including CARBOHSP and CARBOPROP designed for use in deep oil and gas wells; CARBOLITE used in medium depth oil and gas wells; CARBOECONOPROP, a low-density ceramic proppant; CARBOHYDROPROP to enhance performance in slickwater fracture treatments; and CARBOBOND LITE, a resin-coated ceramic for oil and natural gas wells that are subject to the risk of proppant flow-back. Its ceramic proppants also comprise CARBO NORTHERN WHITE, a frac sand that is used by operators that value quality; CARBONRT, a detectable proppant used to assist operators in determining the locations of fractures in natural gas and oil wells; KRYPTOSPHERE HD, a ceramic proppant engineered to deliver increased conductivity and durability in the highest closure stress wells; and SCALEGUARD, a porous ceramic proppant that is infused with scale-inhibiting chemicals and placed throughout the fracture as part of the hydraulic fracturing process.

The company also provides fracture simulation software under the FracPro brand, as well as offers hydraulic fracture design and consulting services under the StrataGen brand. In addition, it provides for spill prevention, containment, and countermeasure systems for the oil and gas industry. The company principally sells its products and services to operators of oil and natural gas wells, and oilfield service companies. CARBO Ceramics Inc. was founded in 1987 and is headquartered in Houston, Texas.

The post CARBO Ceramics Slumps 11% – Idles Operations in Louisiana and Georgia Due to Depressed Oil Prices (NYSE:CRR) appeared first on Sonoran Weekly Review.

Department of State in support of its Bureau of International Narcotics and Law Enforcement Affairs training mission. Separately, the company said Institutional Shareholder Services is also recommending that shareholders vote in favor of the management’s proposals. ARTX was up 8% at $3.77 recently. The new 52-week range is between $1.11 and $3.91.

The stock is up 8.88% or $0.31 after the news, hitting $3.8 per share. About 1.12M shares traded hands or 265.47% up from the average. Arotech Corporation (NASDAQ:ARTX) has risen 140.69% since September 15, 2015 and is uptrending. It has outperformed by 134.41% the S&P500.

Arotech Corporation provides defense and security products worldwide. The company operates in two divisions, Training and Simulation, and Power Systems. The Training and Simulation division develops, manufactures, and markets multimedia and interactive digital solutions for engineering, use-of-force training, and operator training of military, law enforcement, security, emergency services, and other personnel. This division offers simulators, systems engineering support, and software products for training vehicle operators to the United States military, government, municipalities, and private industry; weapon simulations used to train military pilots, weapon employment information used in air launched weapons, and part-task simulators to train aircrew; and specialized use-of-force training simulators and systems for police, security personnel, and the military under the MILO Range trade name.

The Power Systems division provides electronics engineering and design, system integration, rapid prototyping, and vertically production services for military, aerospace, and industrial customers, including hybrid power generation systems, smart power subsystems for military vehicles and dismounted applications, and aircraft and missile systems support for weapons and communications technologies. This division also develops and sells rechargeable and primary batteries, and smart chargers to the military and medical markets, and to private defense industry under the Epsilor name. In addition, it develops, manufactures, and markets primary batteries, rechargeable batteries, and battery chargers for the military; and produces water-activated lifejacket lights for commercial aviation and marine applications under the Electric Fuel name. The company was formerly known as Electric Fuel Corporation and changed its name to Arotech Corporation in September 2003. Arotech Corporation was founded in 1990 and is based in Ann Arbor, Michigan.

The post Arotech Shares Hit Near 2-Yr High; Wins $40 Mln Order For Training Systems Simulator Products (NASDAQ:ARTX) appeared first on Sonoran Weekly Review.

The new capital, which is subject to court approval, will be used by the company to support its continuing business operations, minimize disruption to its worldwide projects and partnerships, and make necessary operational changes. SunEdison CEO Ahmad Chatila said, “The court process will allow us to right-size our balance sheet and reduce our debt, providing the opportunity to support the business going forward while focusing on our core strengths. It also will facilitate our continued work towards transforming the company into a more streamlined and efficient operator, shedding non-core assets as well as taking other steps to help us get the most value out of our technological and intellectual property. SUNE has a 52-week range of $0.20 to $33.45. Shares of TERP and GLBL were up 6% and 7% respectively. Both stocks were moving in the lower half of their respective 52-week ranges.

The stock is down 0.33% or $0.001 after the news, hitting $0.337 per share. About 4.54 million shares traded hands. Sunedison Inc (NYSE:SUNE) has declined 96.98% since September 15, 2015 and is downtrending. It has underperformed by 103.26% the S&P500.

SunEdison, Inc., a renewable energy development company, develops, finances, installs, owns, and operates renewable power plants to residential, commercial, government, and utility customers. It operates through Renewable Energy Development, TerraForm Power, and TerraForm Global segments. The Renewable Energy Development segment provides renewable energy services that integrate the design, installation, financing, monitoring, operations, and maintenance portions of the renewable energy industry segment.

It also owns and operates renewable energy power plants; manufactures polysilicon and silicon wafers; and subcontracts the assembly of solar modules to support downstream solar business, as well as for sale to external customers as market conditions dictate. The TerraForm Power segment owns and operates clean power generation assets that sell electricity through long-term PPAs to utility, commercial, and residential customers based in Organization for Economic Co-operation and Development (OECD) member countries, such as the United States, the United Kingdom, Canada, and Chile. The TerraForm Global segment owns and operates clean power generation assets that sell electricity through long-term PPAs to utility and commercial customers based in specified emerging market countries located in Asia, Africa, Latin America, and the Middle East. The company was formerly known as MEMC Electronic Materials, Inc. and changed its name to SunEdison, Inc. in May 2013. SunEdison, Inc. was founded in 1984 and is headquartered in Maryland Heights, Missouri.

The post SunEdison Shares Halted – Begins Chapter 11 Reorganization (NYSE:SUNE) appeared first on Sonoran Weekly Review.

The stock is 0.00% or $0 after the news, hitting $0.64 per share. It is down 81.12% since September 15, 2015 and is downtrending. It has underperformed by 87.41% the S&P500.

Pacific Exploration and Production Corporation is a Canada firm engaged in exploration, development and production of natural gas and crude oil. The company has a market cap of $190.21 million. The Company’s producing fields are located in Colombia and Peru. It currently has negative earnings. As of December 31, 2014, it drilled or was a partner in 56 wells consisting of 27 exploration wells, 25 appraisal wells and four stratigraphic wells.

The post Pacific Exploration & Production Details Support Agreement With Certain Of Its Noteholders, Lenders And Catalyst Capital (TSE:PRE) appeared first on Sonoran Weekly Review.

Approximately 1,000 direct and indirect employees and contractors have been affected by the disruption, the miner noted. Aura said it is confident that a resolution will be forthcoming as it works with all parties to peacefully resolve the situation. This isn’t the first time operations have been disrupted at San Andres. A similar occupation took place in November of last year, according to Reuters. ORA shares closed at $0.25 on Wednesday.

The stock is down 12.00% or $0.03 after the news, hitting $0.22 per share. About 649,750 shares traded hands or 302.60% up from the average. Aura Minerals Inc. (TSE:ORA) has risen 257.14% since September 15, 2015 and is uptrending. It has outperformed by 250.86% the S&P500.

Aura Minerals Inc. is a Canada gold‐copper production firm focused on the operation and development of gold and copper projects in the Americas. The company has a market cap of $58.20 million. The Company’s assets include The San Andres Gold Mine (San Andres), The Sao Francisco Gold Mine (Sao Francisco), The Aranzazu Copper Mine (Aranzazu) and The Serrote da Laje Project (Serrote). It currently has negative earnings. The Firm owns a 100% interest in San Andres mine, an open‐pit heap leach gold mine located in the highlands of western Honduras.

The post Aura Minerals Suspends Operations at San Andres Mine in Honduras Following Occupation by Local Community (TSE:ORA) appeared first on Sonoran Weekly Review.

Ring granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares from the company at the offering price, it said in a statement early Thursday. The sale is expected to be closed on April 26. The company intends to use the net proceeds from this offering to fund a pilot horizontal drilling program and repay debt under its revolving credit facility. Ring shares trade near the bottom end of their 52-week price range of $4 – $13.41.

The stock is down 9.45% or $0.64 after the news, hitting $6.13 per share. About 2.59M shares traded hands or 1919.98% up from the average. Ring Energy Inc (NYSEMKT:REI) has declined 30.92% since September 15, 2015 and is downtrending. It has underperformed by 37.20% the S&P500.

Ring Energy, Inc. engages in the acquisition, exploration, development, and production of oil and natural gas in Texas and Kansas, the United States. As of December 31, 2015, the companyÂ’s proved reserves consisted of approximately 24.4 million barrel of oil equivalent.

It also has interests in 18,130 net developed and undeveloped acres in Andrews and Gaines counties, and 19,679 net developed and undeveloped acres in Reeves and Culberson counties, Texas; and 16,674 net acres in Kansas. Ring Energy, Inc. primarily sells its oil and natural gas production to end users, marketers, and other purchasers. The company was formerly known as Transglobal Mining Corp. and changed its name to Ring Energy, Inc. in March 2008. Ring Energy, Inc. was founded in 2004 and is headquartered in Midland, Texas.

The post Ring Energy Says Priced Underwritten Common-Stock Sale of 10 Mln Shares at $5.60, Generating $53 Mln (NYSEMKT:REI) appeared first on Sonoran Weekly Review.

As announced on March 20, 2016, Bankers has entered into a definitive agreement with affiliates of Geo-Jade for the purchase of all the issued and outstanding common shares of Bankers at a cash price of $2.20 per Bankers share. If approved at the special meeting, closing of the arrangement will occur in June 2016, following which Bankers shares will be delisted from the Toronto Stock Exchange and the AIM market of the London Stock Exchange. Bankers’ board of directors has recommended shareholders vote in favour of the deal, noting that the offer represented a 98% premium over Bankers’ closing price on the TSX of $1.11 on March 18, 2016. Since then, Bankers’ shares have climbed substantially, closing at $1.81 on Wednesday.

The stock is up 1.10% or $0.02 after the news, hitting $1.83 per share. About 447,630 shares traded hands. Bankers Petroleum Ltd (TSE:BNK) has declined 6.70% since September 15, 2015 and is downtrending. It has underperformed by 12.99% the S&P500.

Bankers Petroleum Ltd. is a Canada oil exploration and production firm with a focus on petroleum assets in Albania. The company has a market cap of $475.53 million. The Firm generates all of its oil revenue from its activities in Albania, which is located northwest of Greece in South Eastern Europe. It currently has negative earnings. Bankers operate and have the full rights to develop the Patos-Marinza and Kucova oilfields in Albania pursuant to License Agreements with the Albanian National Agency for Natural Resources (AKBN) and Petroleum Agreements with Albpetrol Sh.A (Albpetrol), the state-owned oil and Gas Corporation.

The post Bankers Petroleum Files Information Circular Ahead of Special Meeting to Consider Acquisition by Geo-Jade (TSE:BNK) appeared first on Sonoran Weekly Review.

The stock is 0.00% or $0 after the news, hitting $0.145 per share. It is down 100.00% since September 15, 2015 and is uptrending. It has outperformed by 93.72% the S&P500.

Avcorp Industries Inc. is a Canada-based firm that creates and manufactures airframe structures for aircraft manufacturers and to their suppliers. The company has a market cap of $45.89 million. The Firm offers integrated composite and metallic aircraft structures to aircraft manufacturers. It currently has negative earnings. It is a supplier for engineering design, manufacture and assembly of subassemblies and complete structures for aircraft manufacturers.

The post Avcorp Industries Says Mark van Rooij to Resign as President, CEO of Avcorp Delta; Promotes Ed Merlo to Group CFO (TSE:AVP) appeared first on Sonoran Weekly Review.

The stock closed at $86.23 during the last session. It is down 25.02% since September 15, 2015 and is downtrending. It has underperformed by 31.30% the S&P500.

GW Pharmaceuticals plc, a biopharmaceutical company, together with its subsidiaries, engages in discovering, developing, and commercializing cannabinoid prescription medicines. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company primarily offers Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis.

It also focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain; and Phase 2 trials in other indications, such as neuropathic pain. In addition, the companyÂ’s product pipeline includes Epidiolex, a treatment for Dravet syndrome and Lennox-Gastaut syndrome, as well as other product candidates in Phase 1 and 2 clinical development for the treatment of glioma, adult epilepsy, type-2 diabetes, and schizophrenia. It operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

The post GW Pharmaceuticals Receives Orphan Drug Status from FDA for Cannabidiol for Tuberous Sclerosis Complex Treatment (NASDAQ:GWPH) appeared first on Sonoran Weekly Review.

People’s United Financial (NASDAQ:PBCT) reported its subsidiary People’s United Insurance Agency (PUIA) has acquired Eagle Insurance Group, a Raynham, MA-based insurance brokerage firm. “The acquisition deepens our presence in eastern Massachusetts while expanding PUIA’s heating oil and propane supplier relationships and expertise in the commercial segment,” said Jack Barnes, chief executive officer of PUIA. Formed in 2010, Eagle Insurance provides property-liability insurance, risk management, and consultation services to a diverse clientele including petroleum marketers, contractors, and manufacturers, according to a People’s United statement early Thursday. People’s United shares, which were flat in pre-market after closing up 0.8% Wednesday, trade near the top end of their 52-week price range of $13.62 – $16.95.

The stock increased 0.80% or $0.13 during the last trading session, hitting $16.48. People’s United Financial, Inc. (NASDAQ:PBCT) has risen 4.97% since September 15, 2015 and is uptrending. It has underperformed by 1.32% the S&P500.

PeopleÂ’s United Financial, Inc. operates as the bank holding company for PeopleÂ’s United Bank, National Association that provides commercial banking, retail banking, and wealth management services to individual, corporate, and municipal customers. The company operates in two segments, Commercial Banking and Retail Banking. The Commercial Banking segment offers commercial real estate lending, commercial and industrial lending, and commercial deposit gathering services. This segment also provides equipment financing; cash management, correspondent banking, and municipal banking services; institutional trust, corporate trust, private banking, and insurance services.

The Retail Banking segment offers consumer lending, including residential mortgage and home equity lending; and consumer deposit gathering services. This segment also provides brokerage, financial advisory, investment management, life insurance, and non-institutional trust services. The company also offers online banking, investment trading, and telephone banking services. It operates through a network of 396 branches and 594 ATMs in Connecticut, southeastern New York, Massachusetts, Vermont, New Hampshire, and Maine. PeopleÂ’s United Financial, Inc. was founded in 1842 and is headquartered in Bridgeport, Connecticut.

The post People’s United Financial Says Unit Buys Eagle Insurance Group to Deepen Presence in Eastern Massachusetts (NASDAQ:PBCT) appeared first on Sonoran Weekly Review.

The stock decreased 0.57% or $0.01 on April 20, hitting $1.74. Pluristem Therapeutics Inc. (NASDAQ:PSTI) has declined 20.00% since September 15, 2015 and is downtrending. It has underperformed by 26.28% the S&P500.

Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related technologies for the treatment of various ischemic and inflammatory conditions. Its patented placenta expanded (PLX) cells function as a platform that releases a number of therapeutic proteins in response to various local and systemic inflammatory and ischemic signals generated by the patient.

The companyÂ’s PLX cells are grown using proprietary 3D micro-environment technology that produces an off-the-shelf allogeneic cell therapy products. It also develops PLX-PAD cells, which are in Phase-II clinical trial for use in the treatment of peripheral and cardiovascular, orthopedic, and pulmonary diseases, as well as for hematological and womenÂ’s health diseases; and PLX-R18 cells for the treatment of bone marrow failure from various causes and acute radiation syndrome. In addition, the company is involved in the development and commercialization of a PLX cells for the treatment of pulmonary arterial hypertension through its license agreement with the United Therapeutics Corporation; commercialization agreement with CHA Biotech Co. Ltd.; and collaborative research agreement with the Berlin-Brandenburg Center for Regenerative Therapy. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel.

The post Pluristem Therapeutics Signs Licensing Deal with TES Holdings for Placental Cell Therapy Patent (NASDAQ:PSTI) appeared first on Sonoran Weekly Review.

Wal-Mart Stores (NYSE:WMT) shares rose slightly in post-market trading after the company announced changes to its board that included ordinary-course retirements of four members and a reduction in size to maximize effectiveness in supporting the company’s strategy. The changes will take effect following an annual shareholders’ meeting June 3, according to a statement late Wednesday.

Current board members Aida Alvarez, Roger Corbett, Mike Duke and Jim Walton will not stand for re-election. The company also announced that as part of the board’s succession planning, Steuart Walton has been nominated to stand for election. These changes will reduce the number of directors serving on the board from 15 to 12 directors, the statement added. Shares trade in the upper half of their 52-week price range of $56.30 – $80.93.

The stock decreased 0.79% or $0.55 during the last trading session, hitting $69.22. About 5.41M shares traded hands. Wal-Mart Stores, Inc. (NYSE:WMT) has risen 7.60% since September 15, 2015 and is uptrending. It has outperformed by 1.32% the S&P500.

Wal-Mart Stores, Inc. operates retail stores in various formats worldwide. It operates through three segments: Walmart U.S., Walmart International, and SamÂ’s Club. The company operates discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, cash and carry stores, home improvement stores, specialty electronics stores, apparel stores, drug stores, convenience stores, and membership-only warehouse clubs; and retail Websites, such as walmart.com and samsclub.com. It offers grocery products, including meat, produce, natural and organics, deli and bakery, dairy, frozen foods, alcoholic and nonalcoholic beverages, floral and dry grocery, as well as consumables, such as health and beauty aids, baby products, household chemicals, paper goods, and pet supplies; and health and wellness products, which include pharmacy, optical services, clinical services, over-the-counter drugs, and other medical products.

The company also provides electronics, toys, cameras and supplies, photo processing services, cellular phones, cellular service plan contracts and prepaid service, movies, music, video games, and books; stationery, automotive, hardware and paint, and sporting goods, as well as fabrics, crafts, and seasonal merchandise; apparel for women, girls, men, boys, and infants, as well as shoes, jewelry, and accessories; and home furnishings, housewares and small appliances, bedding, home decor, outdoor living, and horticulture products. The company also provides fuel and financial services and related products, including money orders, prepaid cards, wire transfers, money transfers, check cashing, and bill payment. In addition, it offers brand name merchandise, including hardgoods, softgoods, and selected private-label items, such as MemberÂ’s Mark. As of January 31, 2016, it operated 11,865 stores under 63 banners in 28 countries and e-commerce Websites in 11 countries. Wal-Mart Stores, Inc. was founded in 1945 and is headquartered in Bentonville, Arkansas.

The post Wal-Mart Stores Rise Slightly in Post-Market Trading; Company Cuts Size of its Board to 12 From 15 (NYSE:WMT) appeared first on Sonoran Weekly Review.

Todd M. Pope, president and CEO of TransEnterix, said, “The FDA’s decision is extremely disappointing. We are in the process of reviewing all aspects of the FDA’s communication. We will work to complete this review, and will provide an update on the regulatory strategy for the SurgiBot System together with our first quarter 2016 financial and operating results during our quarterly conference call on May 10, 2016.” TransEnterix will release Q1 2016 financial and operating results on May 10, 2016.

The stock decreased 0.84% or $0.04 on April 20, hitting $4.73. About 3.12M shares traded hands or 17.29% up from the average. Transenterix Inc (NYSEMKT:TRXC) has risen 83.01% since September 15, 2015 and is uptrending. It has outperformed by 76.73% the S&P500.

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems. The company offers ALF-X System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. The company also develops SurgiBot System, a single-incision, patient-side robotic-assisted surgery system. In addition, it develops and manufactures flexible and rigid laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

The post TransEnterix Tumbles 65% – FDA Says SurgiBot System Does Not Meet Criteria for 510(k) Submission appeared first on Sonoran Weekly Review.

The stock increased 1.10% or $0.21 during the last trading session, hitting $19.37. About 605,113 shares traded hands. Banc of California Inc (NYSE:BANC) has risen 52.88% since September 15, 2015 and is uptrending. It has outperformed by 46.60% the S&P500.

Banc of California, Inc. operates as the bank holding company for Banc of California, National Association that provides banking products and services in the United States. It operates through Commercial Banking, Mortgage Banking, Financial Advisory, and Corporate/Other segments. The companyÂ’s deposits consist of savings, checking, money market, and demand accounts, as well as certificates of deposit; and commercial and consumer loan products include commercial and industrial loans, commercial real estate loans, multi-family loans, SBA guaranteed business loans, construction and renovation loans, lease financing, single family residential mortgage loans, warehouse loans, asset or security backed loans, home equity lines of credit, consumer and business lines of credit, home equity loans, and other consumer loans. It also provides private banking products for high net worth individuals and entrepreneurs; and other banking services to financial institutions, as well as invests in mortgage-backed securities.

In addition, the company offers automated bill payment, cash and treasury management, master demand accounts, foreign exchange, interest rate swaps, trust services, card payment services, remote and mobile deposit capture, ACH origination, wire transfer, direct deposit, and safe deposit boxes, as well as online, telephone, and mobile banking services. Further, it provides financial advisory and asset management services to third parties; and manages and sells other real estate owned properties. As of December 31, 2015, the company operated 35 branches in San Diego, Orange, Santa Barbara, and Los Angeles Counties in California; and 68 loan production offices in California, Arizona, Oregon, Virginia, Indiana, Colorado, Idaho, and Nevada. Banc of California, Inc. was formerly known as First PacTrust Bancorp, Inc. and changed its name to Banc of California, Inc. in July 2013. The company was founded in 1941 and is headquartered in Irvine, California.

The post Banc of California Rises in After-Hours Trading as Company Announces Expansion of Line of Credit to $75 Mln (NYSE:BANC) appeared first on Sonoran Weekly Review.

Thousands of Verizon Communications (NYSE:VZ) customers were cut off from critical services over the past few days as criminals damaged or destroyed critical network facilities. There have been at least 24 suspected incidents of sabotage over the past week in five states in which services were cut off for thousands of residential and business customers, including a local police and fire department in New Jersey, according to a company statement late Wednesday. The company is offering a reward of up to $10,000 for information leading to the arrest and prosecution of individuals who intentionally damage Verizon cables or facilities. Verizon shares, which rose 1.8% at the close Wednesday and traded flat in after-hours, remain in the lower half of their 52-week price range of $1.60 – $3.15.

The stock decreased 0.65% or $0.34 during the last trading session, hitting $51.74. About 15.41M shares traded hands or 13.23% up from the average. Verizon Communications Inc. (NYSE:VZ) has risen 11.60% since September 15, 2015 and is uptrending. It has outperformed by 5.32% the S&P500.

Verizon Communications Inc., through its subsidiaries, provides communications, information, and entertainment products and services to consumers, businesses, and governmental agencies worldwide. Its Wireless segment offers wireless voice and data services; messaging services; wireless Internet access services on notebook computers and tablets; multimedia access services; business-focused services; location-based services; global data services; home phone connect services; high-speed Internet service; and network access and value added services to support wireless connections for the Internet of Things (IoT). This segment also provides IoT services that support devices used in health monitoring, education, manufacturing, utilities, distribution, and consumer products markets, as well as offers wireless devices, including smartphones and basic phones, tablets, and other Internet access devices.

As of December 31, 2015, it had 112.1 million retail connections. The companyÂ’s Wireline segment provides high-speed Internet, Fios Internet, and Fios video services; voice services, such as local exchange, regional and long distance calling, and voice messaging services, as well as VoIP services; network products and solutions comprising private Internet protocol (IP), public Internet, Ethernet, and optical networking services; IT infrastructure services, including collocation and managed hosting; cloud services, such as computing, storage, backup, recovery, and application platforms; and business communications services. This segment also offers IoT services; data security services; voice and data services; and data, voice, local dial tone, and broadband services primarily to local, long distance, and other carriers. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was founded in 1983 and is based in New York, New York.

The post Verizon Communications Customers Put Out of Service by Cable Cutting and Damaging Network Facilities (NYSE:VZ) appeared first on Sonoran Weekly Review.

The stock increased 6.00% or $0.18 on April 20, hitting $3.18. About 22,312 shares traded hands or 35.14% up from the average. Alon Blue Square Israel Ltd (NYSE:BSI) has declined 55.88% since September 14, 2015 and is downtrending. It has underperformed by 63.45% the S&P500.

Alon Blue Square Israel Ltd. operates as a retail company in Israel. Its Fueling and Commercial Sites segment develops, constructs, and operates vehicle fueling stations, adjacent commercial centers, and independent convenience stores; markets fuel and other products through filling stations and convenience stores; and directly markets distillates to customers. As of December 31, 2014, this segment operated 209 fueling stations; and 215 convenience stores under the Alonit and Super Alonit, and AM:PM names.

The companyÂ’s Supermarkets segment offers various food and beverage products; non-food items, such as house wares, toys, small electrical appliances, computers and computer accessories, entertainment and leisure products, and textile products; and near-food products comprising health and beauty aids, products for infants, cosmetics, and hygiene products. This segment operates 197 supermarkets under the You, ZolBeShefa, You Neighborhood Store, Mega, Mega in Town, and Eden Teva brands. Its Houseware and Textile segment operates as a retailer and wholesaler in houseware and textile activities.

This segment operates 112 stores under the Naaman and Vardinon barnds. The company’s Real Estate segment owns, leases, and develops commercial centers, logistics centers and offices, and land, as well as develops wholesale market residency projects in Tel-Aviv. Alon Blue Square Israel Ltd. is also involved in the cellular mobile virtual network operator activities, as well as issuance and clearance of credit card activities. The company was formerly known as Alon Holdings Blue Square – Israel Ltd. and changed its name to Alon Blue Square Israel Ltd. in April 2013. The company was founded in 1988 and is based in Yakum, Israel. Alon Blue Square Israel Ltd. operates as a subsidiary of Alon Israel Oil Company Ltd.

The post Alon Blue Square Israel Adds 5%, Gets 15-Day Window to Negotiate Acquisition of Mega Retail (NYSE:BSI) appeared first on Sonoran Weekly Review.

Yahoo! (NASDAQ:YHOO) shares jumped 4.5% after the parent group of British tabloid The Daily Mail said Wednesday it has not made a bid for the Internet company, but remained in talks with interested parties. “Daily Mail and General Trust would like to clarify that it has not submitted a bid to purchase Yahoo,” the company said in a brief statement to the LSE. “It remains in discussions with parties who may potentially be interested in Yahoo. DMGT has no further comment at this time.” Yahoo shares trade in the upper half of their 52-week range of $26.15 – $45.18.

The stock increased 4.16% or $1.51 during the last trading session, hitting $37.84. About 30.76M shares traded hands or 87.56% up from the average. Yahoo! Inc. (NASDAQ:YHOO) has risen 19.82% since September 14, 2015 and is uptrending. It has outperformed by 12.26% the S&P500.

Yahoo! Inc., together with its subsidiaries, provides search and display advertising services on Yahoo properties and affiliate sites worldwide. The company offers Yahoo Search that serves as a guide for users to discover information on the Internet; Yahoo Mail, which connects users to the people and content; and Yahoo Messenger, an instant messaging service, which enables users to connect, communicate, and share experiences in real-time. It also provides digital content products, including Yahoo News, which gives users to discover, consume, and engage around the news, content, and video; Yahoo Sports, which serves audiences of sports enthusiasts; Yahoo Finance that offers a range of financial data, information, and tools; Yahoo Lifestyle to engage users passionate about style and fashion; and Tumblr, which provides a Web platform and mobile applications on iOS and android to create, share, and curate content, as well as Tumblr messaging that enables users to engage with other users that share their same interests and passions.

In addition, the company provides advertiser products, such as Yahoo Gemini, a marketplace for search and native advertising; and BrightRoll, which offers a suite of media-agnostic tools to enable advertisers, publishers, and partners connect with users across ad formats and devices. Further, it offers advertising formats; and digital advertising products, such as Yahoo native, Yahoo video, Yahoo premium, and Yahoo audience ads. Additionally, the company offers Yahoo Mobile Developer suite consisting of Flurry Analytics, Yahoo App Publishing, Yahoo App Marketing, and Tumblr In-App Sharing tools to measure, monetize, advertise, and improve their apps. Yahoo! Inc. was founded in 1994 and is headquartered in Sunnyvale, California.

The post Yahoo! Jumps as Daily Mail and General Trust Clarifies Not Made Any Bid, But In Talks With Interested Parties (NASDAQ:YHOO) appeared first on Sonoran Weekly Review.

Food and Drug Administration (FDA) in December 2015 for the treatment of patients with chronic lymphocytic leukemia (CLL) and for the treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. The determination by CMS that existing code J9033 “Injection, bendamustine hcl, 1mg” adequately describes BENDEKA will be followed by a final decision in Q4. The final decision will take effect in January 2017. Shares were up 1.8% at $37.73, with a 52-week range of $33.02 – $104.17.

The stock increased 1.19% or $0.44 during the last trading session, hitting $37.51. About 145,471 shares traded hands. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) has declined 56.12% since September 14, 2015 and is downtrending. It has underperformed by 63.69% the S&P500.

Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban to treat heparin-induced thrombocytopenia; Ryanodex injectable suspension for the treatment of malignant hyperthermia; non-alcohol docetaxel injection, a chemotherapeutic agent for the treatment of breast, non-small cell lung, prostate, head, and neck cancers/gastric adenocarcinoma; and diclofenac-misoprostol. It develops EP-3101, a bendamustine ready to dilute (RTD) liquid; EP-3102, a bendamustine short infusion time RTD liquid for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin’s lymphoma; and EP-4104, a dantrolene for the treatment of exertional heat stroke. The company also develops EP-5101 (pemetrexed) as RTD liquid, which is in pre-clinical formulation and toxicology studies to treat lung cancer and mesothelioma; and EP-6101, a bivalirudin RTU liquid formulation for the treatment of percutaneous transluminal angioplasty. Eagle Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Woodcliff Lake, New Jersey.

The post Eagle Pharmaceuticals Says CMS Determines Existing J-Code J9033 Adequately Describes BENDEKA Injection; Final Decision Expected by January 2017 (NASDAQ:EGRX) appeared first on Sonoran Weekly Review.

The stock is down 4.54% or $1.57 after the news, hitting $33 per share. About 348,014 shares traded hands or 131.51% up from the average. Barrett Business Services, Inc. (NASDAQ:BBSI) has declined 17.58% since September 14, 2015 and is downtrending. It has underperformed by 25.14% the S&P500.

Barrett Business Services, Inc. provides business management solutions for small and medium-sized companies in the United States. The company has management platform that integrates a knowledge-based approach from the management consulting industry with tools from the human resource outsourcing industry.

It offers professional employer services, under which it enters into a client services agreement to become a co-employer of the clientÂ’s existing workforce, assuming responsibility for payroll, payroll taxes, workersÂ’ compensation coverage, and certain other administration functions. The company also provides staffing and recruiting services, such as on-demand or short-term staffing assignments, contract staffing, long-term or indefinite-term on-site management, and direct placement. It serves electronics manufacturers, various light-manufacturing industries, agriculture-based companies, transportation and shipping enterprises, food processing, telecommunications, public utilities, general contractors in various construction-related fields, and professional services firms. Barrett Business Services, Inc. was founded in 1965 and is headquartered in Vancouver, Washington.

The post Barrett Business Services Soars 19% After Forensic Accounting Investigation Finds No Effect on Net Profit, EPS (NASDAQ:BBSI) appeared first on Sonoran Weekly Review.

Benton has acquired by staking a 100% interest in the Wisa Lake Lithium deposit located 80km east of Fort Frances, Ontario. The Company has also agreed to acquire a 100% interest in the Champion Graphite project from Benton Resources Inc. (BEX.V) (a company related by common directorships) for a payment of 1 million shares to Benton Resources Inc. and subject to a 2% NSR. Benton Capital will have the option to buy back 1% of the NSR for $500,000. The Champion Graphite project represents a non-core asset of Benton Resources Inc.

The stock increased 200.00% or $0.04 on April 20, hitting $0.06. About 3.46 million shares traded hands or 9322.66% up from the average. Benton Capital Corp (CVE:BTC) has risen 6.00% since March 22, 2016 and is uptrending. It has underperformed by 1.57% the S&P500.

Benton Capital Corp. is a development-stage company. The company has a market cap of $2.29 million. The Firm is engaged in exploration for mineral deposits in Canada. It currently has negative earnings. The Company’s focus is to seek out and explore mineral properties.

The post TSXV-Listed Benton Capital to Focus on Green Energy Exploration; to Change Name to Alset Energy Corp (CVE:BTC) appeared first on Sonoran Weekly Review.

The stock is up 0.16% or $0.06 after the news, hitting $38.24 per share. About 2.65 million shares traded hands or 37.31% up from the average. Liberty Global plc – Class A Ordinary Shares (NASDAQ:LBTYA) has declined 17.27% since September 14, 2015 and is downtrending. It has underperformed by 24.84% the S&P500.

Liberty Global plc, together with its subsidiaries, provides video, broadband Internet, fixed-line telephony, and mobile services in Europe, Chile, and Puerto Rico. It offers various residential services, including video services comprising basic and premium programming, electronic programming guide, high definition (HD) channel, digital video recorder (DVR), and HD DVR services; and video-on-demand, set-top box, pay-per-view programming, and 3D programming services, as well as television applications that allow access to programming on laptops, smartphones, and tablets. The company provides entertainment, sports, movies, documentaries, lifestyles, news, adult, children, and ethnic and foreign channels.

It also offers broadband Internet services, such as email, address book, and parental controls; security; and online storage solutions and Web spaces. In addition, the company provides telephony services consisting of multi-featured and circuit-switched fixed-line telephony services; and mobile services comprising voice, short message service, and Internet access. Further, it offers voice, broadband Internet, data, video, wireless, and cloud services to small or home offices, small businesses, and medium and large enterprises, as well as on a wholesale basis to other operators. The company distributes its broadband services through cable distribution systems; and video services through direct-to-home satellite and multichannel multipoint distribution systems. Liberty Global plc was founded in 2004 and is based in London, the United Kingdom.

The post Liberty Global Slips After Co. Says Shareholders Approve Acquisition of UK’s Cable & Wireless Communications (NASDAQ:LBTYA) appeared first on Sonoran Weekly Review.

The Company intends to publish these data in the near future. Aralez also said it worked directly with the new primary aspirin supplier to help prepare it for a previously planned inspection by the FDA. The FDA inspection has recently concluded and did not result in any reported compliance findings. YOSPRALA’s FDA Prescription Drug User Fee Act (PDUFA) goal date for a decision is September 14. The company also announced the promotional launch of Fibricor (fenofibric acid), comprised of both the branded product and the Authorized Generic (AG), in the U.S. with a 25 person sales force whose key objectives also include developing relationships with cardiologists. Shares were down 1.5% at $3.94 in recent trade, with a 52-week range of $3.42 – $12.69.

The stock decreased 2.50% or $0.1 during the last trading session, hitting $3.9. About 601,522 shares traded hands. Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) has declined 56.99% since September 14, 2015 and is downtrending. It has underperformed by 64.56% the S&P500.

Aralez Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada, Ireland, and the United States. The company engages in acquiring, developing, and commercializing products primarily in cardiovascular disease, pain, and other specialty areas. It offers Fibricor, a fenofibric acid for the treatment of severe hypertriglyceridemia; Cambia, a non-steroidal anti-inflammatory drug (NSAID) for the acute treatment of migraine attacks with or without aura in adults; Fiorinal and Fiorinal C for the relief of tension type headaches; Soriatane, a retinoid, an aromatic analog of vitamin A for the treatment of severe psoriasis and other disorders of keratinization; and Bezalip SR, a pan-peroxisome proliferator-activated receptor activator to treat hyperlipidemia, as well as to increase insulin sensitivity and decrease blood glucose levels for the patients with metabolic syndrome.

The company also markets NeoVisc, a sodium hylauronic solution; Uracyst, a sodium chondroitin sulfate; Durela, a tramadol hydrochloride; Proferrin, a heme iron polypeptide; Resultz, a isopropyl myristate; Collatamp G, a collagen-gentamycin; and a portfolio of eight products targeted for the areas of gastroenterology and womenÂ’s health. In addition, it develops YOSPRALA 81/40 and 325/40 for secondary prevention of cardiovascular and cerebrovascular disease in patients at risk for gastric ulcers, which have completed Phase III clinical development in the United States; and Bilastine, an antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria. Further, the companyÂ’s out-licensed products include VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers; and Treximet, a migraine medicine. Aralez Pharmaceuticals Inc. is headquartered in Milton, Canada. Aralez Pharmaceuticals Inc. (TSX:ARZ) operates independently of QLT Inc. as of April 05, 2016.

The post Aralez Pharmaceuticals Takes Steps to Support Submission of YOSPRALA NDA; Launches Fibricor (NASDAQ:ARLZ) appeared first on Sonoran Weekly Review.

Express Scripts (NASDAQ:ESRX) shares were higher over 1% on Wednesday after the company denied allegations made by Anthem (ANTM) in a lawsuit filed in March in the U.S. District Court for the Southern District of New York. The lawsuit alleges various breach of contract claims against Express Scripts , relating to the parties’ rights and obligations under the pharmacy benefit management agreement between Express Scripts and Anthem.

Express Scripts said it has filed its answer and made counterclaims, including that Anthem breached the pharmacy benefit management by failing to negotiate in good faith with respect to its own proposed new pricing terms. Among other claims, Express Scripts also said that Anthem breached the implied covenant of good faith and fair dealing under the pharmacy benefit management by disregarding the terms of the transaction in which it negotiated and accepted a $4.68 billion cash payment in 2009. Express said it believes Anthem’s case is without merit but noted that it cannot predict what the outcome of the lawsuit will be. ESRX trades in the lower half of the 52-week range between $65.55 and $94.61. ANTM trades in the lower half of the 52-week range between $115.63 and $173.59.

The stock increased 1.13% or $0.82 during the last trading session, hitting $73.17. About 3.74M shares traded hands. Express Scripts Holding Company (NASDAQ:ESRX) has declined 14.01% since September 14, 2015 and is downtrending. It has underperformed by 21.58% the S&P500.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. The company operates through two segments, PBM and Other Business Operations. The companyÂ’s PBM segmentÂ’s products and services include clinical solutions to enhance health outcomes; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services.

In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services, including design, implementation, and project management for pharmaceutical, biotechnology, and device manufacturers to collect scientific evidence to guide the use of medicines. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workersÂ’ compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2015, the company operated four automated dispensing home delivery pharmacies; one non-automated dispensing home delivery pharmacy; and one non-dispensing home delivery pharmacy maintained for business continuity purpose, as well as several non-dispensing order processing centers, patient contact centers, specialty drug pharmacies, and fertility pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.

The post Express Scripts Denies Anthem Allegations in Lawsuit; Shares Gain 1% (NASDAQ:ESRX) appeared first on Sonoran Weekly Review.

The stock increased 1.52% or $0.01 on April 20, hitting $0.67. About 86,700 shares traded hands or 31.94% up from the average. ImmunoVaccine Inc. (TSE:IMV) has declined 23.26% since September 14, 2015 and is downtrending. It has underperformed by 30.82% the S&P500.

Immunovaccine Inc. is a clinical-stage biopharmaceutical company. The company has a market cap of $63.62 million. The Firm discovers and develops products that activate the immune system to treat cancer and infectious diseases. It currently has negative earnings. The Firm has a product platform that is used to create highly immunogenic vaccines.

The post Immunovaccine Reports New Study on DepoVax Effects (TSE:IMV) appeared first on Sonoran Weekly Review.

Halliburton (NYSE:HAL) is expected to face a formal complaint from European Union officials over its proposed takeover of rival Baker Hughes (BHI) before the end of the month, Bloomberg reported citing two sources close to the matter. The formal complaint, also known as a statement of objections, would spell out regulatory concerns that EU regulators have over the deal, including concerns on how the merger would stifle competition in the EU, the sources added.

The formal complaint follows a civil antitrust lawsuit launched by the U.S. Justice Department earlier this month to block the deal over concerns it would eliminate head-to-head competition, raise prices and reduce innovation in the oilfield services industry. In recent midday trade, HAL was up 1%, moving in the upper half of its 52-week range of $27.64 to $50.20. BHI was inching 0.6% lower, in the lower half of its 52-week range of $37.58 to $70.45.

The stock increased 0.75% or $0.3 during the last trading session, hitting $40.34. About 9.70 million shares traded hands. Halliburton Company (NYSE:HAL) has risen 8.57% since September 14, 2015 and is uptrending. It has outperformed by 1.00% the S&P500.

Halliburton Company provides a range of services and products to the upstream oil and natural gas industry worldwide. The companyÂ’s Completion and Production segment offers production enhancement services, including stimulation and sand control services; and cementing services, such as bonding the well, well casing, and casing equipment. It also provides completion tools that offer downhole solutions and services, including well completion products and services, intelligent well completions, liner hanger systems, sand control systems, and service tools; pressure control services comprising coiled tubing, hydraulic workover units, and downhole tools; and pipeline and process services, such as pre-commissioning and maintenance, subsea pipeline, conventional pipeline, and process services.

In addition, this segment offers oilfield production and completion chemicals and services; electrical submersible pumps and progressive cavity pumps; and installation, maintenance, repair, and testing services. The companyÂ’s Drilling and Evaluation segment provides drilling fluid systems, performance additives, completion fluids, solids control, specialized testing equipment, and waste management services; and drilling systems and services. It also offers wireline and perforating services that include open-hole logging, cased-hole and slickline, borehole seismic, and formation and reservoir solutions; and drill bits and services comprising roller cone rock bits, fixed cutter bits, hole enlargement, and related downhole tools and services, as well as coring equipment and services. In addition, this segment offers integrated exploration, drilling, and production software, as well as related professional and data management services; testing and subsea services, such as acquisition and analysis of reservoir information and optimization solutions; and oilfield project management and integrated solutions. Halliburton Company was founded in 1919 and is based in Houston, Texas.

The post Halliburton to Face Formal EU Complaint on Planned Baker Hughes Deal: Bloomberg (NYSE:HAL) appeared first on Sonoran Weekly Review.

Bird fauna inventories to complement the currently available information on migratory birds, especially shorebirds, raptors and waterfowl. Sampling of the herpetofauna by installing automatic recording stations to record frog calls to establish a list of species that use the site. Others inventories and survey are plan to be completed during the summer period of 2016. These works are part of the feasibility study and will be completed by WSP Canada Inc.

The stock is down 1.47% or $0.005 after the news, hitting $0.335 per share. About 243,565 shares traded hands. Critical Elements Corp (CVE:CRE) has risen 6.00% since March 21, 2016 and is uptrending. It has underperformed by 1.57% the S&P500.

Critical Elements Corporation is a Canada exploration company. The company has a market cap of $43.47 million. The Firm is involved in the acquisition, exploration and development of mining properties. It currently has negative earnings. The Company’s properties include Rose Lithium-Tantalum property, Amiral property, Arques property, Bourier property, Caumont property, Dumulon property, Duval property, Lemare property, Nisk property, Valiquette Property and British Columbia Rare Earth properties.

The post TSXV-Listed Critical Elements Begin Enviro Work at Rose Lithium Project (CVE:CRE) appeared first on Sonoran Weekly Review.

Lawyers for Wynn Resorts (NASDAQ:WYNN) co-founder, Elaine Wynn, filed a motion in the Nevada Clark County Court to compel further disposition of former Nevada governor and Wynn Resorts director, Robert Miller. The motion seeks to compel Governor Miller to answer questions about whether the board fulfilled its fiduciary responsibilities to its shareholders, and provide clarity on the decision not to renominate Ms.

Wynn to the board, the first time that the Wynn board did not renominate a current board member. Ms. Wynn contends that Wynn Resorts lacks effective internal controls, a strong and independent board, and that the current board of directors is controlled by founder Steven Wynn and Wynn Resorts’ general counsel, Kimmarie Sinatra. Shares are down by more than 1% at $98.89 with a 52-week range of $49.95 to $132.00.

The stock is up 0.68% or $0.68 after the news, hitting $100.67 per share. About 1.52M shares traded hands. Wynn Resorts, Limited (NASDAQ:WYNN) has risen 46.03% since September 14, 2015 and is uptrending. It has outperformed by 38.47% the S&P500.

Wynn Resorts, Limited, together with its subsidiaries, develops, owns, and operates destination casino resorts. It operates in two segments, Macau Operations and Las Vegas Operations. The company operates Wynn Macau and Encore at Wynn Macau resort located in the PeopleÂ’s Republic of China.

As of February 12, 2016, its Macau resorts feature had approximately 284,000 square feet of casino space, which offered 24-hour gaming and a range of games with 458 table games and 708 slot machines, private gaming salons, sky casinos, and a poker; 2 luxury hotel towers with a total of 1,008 guest rooms and suites; casual and fine dining in 8 restaurants; approximately 57,000 square feet of retail shopping, including stores and boutiques; approximately 31,000 square feet of space for lounges and meeting facilities; recreation and leisure facilities, including 2 health clubs, spas, a salon, and a pool; and the Rotunda show. The company also owned and operated Wynn Las Vegas and Encore at Wynn Las Vegas resort with a total of 4,748 hotel rooms, suites, and villas; 232 table games; 1,866 slot machines; a race and sports book and poker room in approximately 186,000 square feet of casino gaming space, including a sky casino and private gaming salons; 34 food and beverage outlets; 2 spas and salons; lounges; and approximately 99,000 square feet of retail shopping space. Its Las Vegas resorts also offer 3 nightclubs and a beach club; wedding chapels; an 18-hole golf course; approximately 290,000 square feet of meeting and convention space; a theater; and 2 showrooms, as well as a water-based theatrical production and entertainment production. Wynn Resorts, Limited was founded in 2002 and is based in Las Vegas, Nevada.

The post Wynn Resorts Co-Founder Seeks to Force Former Nevada Governor to Provide Testimony (NASDAQ:WYNN) appeared first on Sonoran Weekly Review.

The stock is up 3.12% or $0.27 after the news, hitting $9.07 per share. About 488,364 shares traded hands. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) has risen 12.24% since September 14, 2015 and is uptrending. It has outperformed by 4.68% the S&P500.

JA Solar Holdings Co., Ltd., together with its subsidiaries, designs, develops, manufactures, and sells photovoltaic solar cells and solar power products based on crystalline silicon technologies. The companyÂ’s principal products include monocrystalline and multicrystalline solar cells and modules.

It also provides monocrystalline and multicrystalline silicon wafers; solar product processing services; and engineering, procurement, and construction services to independent power project developers and public utility companies. The company sells its products primarily under the JA Solar brand name, as well as produces original equipment for manufacturers or customers under their brand names. JA Solar Holdings Co., Ltd. sells its solar cell and module products to module manufacturers, system integrators, project developers, and distributors worldwide. The company was founded in 2005 and is based in Shanghai, the PeopleÂ’s Republic of China.

The post JA Solar Says Was Served With Lawsuit Brought By Hemlock Semiconductor (NASDAQ:JASO) appeared first on Sonoran Weekly Review.

The stock is up 2.21% or $0.32 after the news, hitting $14.79 per share. About 3,939 shares traded hands. Capital City Bank Group, Inc. (NASDAQ:CCBG) has declined 3.47% since September 14, 2015 and is downtrending. It has underperformed by 11.04% the S&P500.

Capital City Bank Group, Inc. operates as a bank holding company for Capital City Bank that provides commercial and retail banking services to individuals and corporate clients. It offers a range of consumer banking services, including checking accounts, savings programs, automated teller machines, debit/credit cards, night deposit services, safe deposit facilities, online banking, and mobile banking. The company also provides financing for commercial business properties, equipment, inventories, and accounts receivable, as well as commercial leasing and letters of credit; commercial and residential real estate lending solutions, including conventional permanent and construction/permanent (fixed, adjustable, or variable rate) financing arrangements, and FHA/VA loan products; and retail credit products, such as personal loans, automobile loans, boat/RV loans, home equity loans, and credit card programs. In addition, it offers institutional banking services, such as cash management systems, tax-exempt loans, lines of credit, and term loans for state and local governments, public schools and colleges, charities, membership, and not-for-profit associations; and treasury management and merchant credit card transaction processing services.

Further, it offers asset management for individuals through agency, personal trust, IRA, and personal investment management accounts, as well as services for the administration of pension, profit sharing, and 401(k) plans; and retail securities products, including U.S. Government bonds, tax-free municipal bonds, stocks, mutual funds, unit investment trusts, annuities, life insurance, and long-term health care. Additionally, the company provides data processing services to financial institutions, government agencies, and commercial clients. As of February 29, 2016, it operated 61 banking offices in Florida, Georgia, and Alabama. Capital City Bank Group, Inc. was founded in 1895 and is headquartered in Tallahassee, Florida.

The post Capital City Bank Group Shareholder Broad Lane Urges Action to Address Underperformance (NASDAQ:CCBG) appeared first on Sonoran Weekly Review.

The stock is up 2.21% or $0.32 after the news, hitting $14.79 per share. About 3,939 shares traded hands. Capital City Bank Group, Inc. (NASDAQ:CCBG) has declined 3.47% since September 14, 2015 and is downtrending. It has underperformed by 11.04% the S&P500.

Capital City Bank Group, Inc. operates as a bank holding company for Capital City Bank that provides commercial and retail banking services to individuals and corporate clients. It offers a range of consumer banking services, including checking accounts, savings programs, automated teller machines, debit/credit cards, night deposit services, safe deposit facilities, online banking, and mobile banking. The company also provides financing for commercial business properties, equipment, inventories, and accounts receivable, as well as commercial leasing and letters of credit; commercial and residential real estate lending solutions, including conventional permanent and construction/permanent (fixed, adjustable, or variable rate) financing arrangements, and FHA/VA loan products; and retail credit products, such as personal loans, automobile loans, boat/RV loans, home equity loans, and credit card programs. In addition, it offers institutional banking services, such as cash management systems, tax-exempt loans, lines of credit, and term loans for state and local governments, public schools and colleges, charities, membership, and not-for-profit associations; and treasury management and merchant credit card transaction processing services.

Further, it offers asset management for individuals through agency, personal trust, IRA, and personal investment management accounts, as well as services for the administration of pension, profit sharing, and 401(k) plans; and retail securities products, including U.S. Government bonds, tax-free municipal bonds, stocks, mutual funds, unit investment trusts, annuities, life insurance, and long-term health care. Additionally, the company provides data processing services to financial institutions, government agencies, and commercial clients. As of February 29, 2016, it operated 61 banking offices in Florida, Georgia, and Alabama. Capital City Bank Group, Inc. was founded in 1895 and is headquartered in Tallahassee, Florida.

The post Capital City Bank Group Shareholder Broad Lane Urges Action to Address Underperformance (NASDAQ:CCBG) appeared first on Sonoran Weekly Review.

Office Depot (NASDAQ:ODP) and Staples (SPLS) are trading defensively Wednesday as investors brace for a decision by a federal judge that could impact their multi-billion dollar merger. According to Reuters, attorneys for both the Federal Trade Commission (FTC) and Staples gave their closing arguments on Tuesday. The FTC is seeking a preliminary injunction to stop the proposed $6.3 million merger pending a decision by an FTC judge. The decision hinges on whether the judge decides that the merger will stifle competition and create a monopoly in the office supply business.

The judge shut down several arguments by Staples’ attorney, leading investors to believe that his decision will scuttle the merger. The FTC has been successful before in stopping an Office Depot/Staples merger in 1997. Office Depot went on to buy OfficeMax in November 2013. Shares of Staples are down close to 2% at $10.85 with a 52-week range of $8.03 to $16.84. Office Depot is down more than 6% at $6.43 with a 52-week range of $4.83 to $9.40.

The stock is down 6.41% or $0.44 after the news, hitting $6.42 per share. About 16.98 million shares traded hands or 38.73% up from the average. Office Depot Inc (NASDAQ:ODP) has declined 6.92% since September 14, 2015 and is downtrending. It has underperformed by 14.49% the S&P500.

Office Depot, Inc., together with its subsidiaries, supplies office products and services. It operates in three segments: North American Retail, North American Business Solutions, and International. The company sells office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture. It also offers copy and print services.

The company sells its products and services to consumers and businesses through office supply stores, a contract sales force, Internet sites, an outbound telephone account management sales force, direct marketing catalogs, and call centers, as well as participates under licensing and merchandise arrangements in Latin America, Europe, Israel, and Japan. As of December 26, 2015, it operated 1,564 stores in the United States, including Puerto Rico and the U.S. Virgin Islands; and 147 stores in France, South Korea, Sweden, New Zealand, and Australia. The company offers its products under various labels, including Office Depot, OfficeMax, Foray, Ativa, TUL, Realspace, WorkPro, Brenton Studio, Highmark, Grand & Toy, and Viking Office Products. Office Depot, Inc. was founded in 1986 and is headquartered in Boca Raton, Florida.

The post Office Depot and Staples Brace for Federal Judge Decision that Could Scuttle $6.3 Bln Merger (NASDAQ:ODP) appeared first on Sonoran Weekly Review.

The stock is down 0.33% or $2.55 after the news, hitting $773.7 per share. About 912,069 shares traded hands. Alphabet Inc (NASDAQ:GOOGL) has risen 18.97% since September 14, 2015 and is uptrending. It has outperformed by 11.40% the S&P500.

Alphabet Inc., through its subsidiaries, provides online advertising services in the United States, the United Kingdom, and rest of the world. The company offers performance and brand advertising services. It operates through Google and Other Bets segments.

The Google segment includes principal Internet products, such as Search, Ads, Commerce, Maps, YouTube, Apps, Cloud, Android, Chrome, and Google Play, as well as technical infrastructure and newer efforts, such as Virtual Reality. This segment also sells hardware products comprising Chromecast, Chromebooks, and Nexus. The Other Bets segment includes businesses, such as Access/Google Fiber, Calico, Nest, Verily, GV, Google Capital, X, and other initiatives. Alphabet Inc. was founded in 1998 and is headquartered in Mountain View, California.

The post Alphabet’s Google Receives Antitrust Charges in Europe For Abusing Dominance of Android OS (NASDAQ:GOOGL) appeared first on Sonoran Weekly Review.

The stock is down 10.50% or $0.021 after the news, hitting $0.179 per share. About 4.90 million shares traded hands. Energy XXI Ltd (NASDAQ:EXXI) has declined 86.21% since September 14, 2015 and is downtrending. It has underperformed by 93.77% the S&P500.

Energy XXI Ltd. provides acquisition, exploration, development, and operation of oil and natural gas properties in Louisiana, Texas, and the Gulf of Mexico. As of June 30, 2015, the company has net proved reserves of 183.5 million barrels of oil equivalent. It operates an interest in 567 gross producing wells on 388,199 net developed acres, including interests in 52 producing fields.

The company was formerly known as Energy XXI (Bermuda) Limited and changed its name to Energy XXI Ltd. in November 2014. The company was founded in 2005 and is based in Houston, Texas. On April 14, 2016, Energy XXI Ltd., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.

The post Energy XXI Shares Drop 13%; Doesn’t Plant to Appeal Nasdaq Decision to Delist Shares (NASDAQ:EXXI) appeared first on Sonoran Weekly Review.

The stock is up 5.54% or $0.97 after the news, hitting $18.49 per share. About 307,752 shares traded hands or 9.31% up from the average. Gibson Energy Inc. (TSE:GEI) has declined 0.90% since September 14, 2015 and is downtrending. It has underperformed by 8.47% the S&P500.

Gibson Energy Inc. is an integrated service well-known provider to the gas and oil industry with activities across regions throughout North America. The company has a market cap of $2.42 billion. Gibson is engaged in the movement, storage, blending, processing, marketing and distribution of crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste and refined products. It currently has negative earnings. The Firm operates through six divisions: Terminals and Pipelines, Environmental Services, Truck Transportation, Propane and NGL Marketing and Distribution, Processing and Wellsite Fluids, and Marketing.

The post Gibsons Energy Details New Management Structure and Changes to Segmented Reporting; Shares Up Over 1% (TSE:GEI) appeared first on Sonoran Weekly Review.

The stock is up 6.86% or $0.29 after the news, hitting $4.52 per share. About 193,631 shares traded hands or 81.55% up from the average. GOLDMONEY INC (CVE:XAU) has risen 6.00% since March 21, 2016 and is uptrending. It has underperformed by 1.57% the S&P500.

The post TSXV-Listed GoldMoney Graduates to the Toronto Stock Exchange; Stock Rises 3% (CVE:XAU) appeared first on Sonoran Weekly Review.

The stock is down 0.23% or $0.11 after the news, hitting $47.44 per share. About 363,529 shares traded hands. Emera Inc (TSE:EMA) has risen 14.03% since September 14, 2015 and is uptrending. It has outperformed by 6.46% the S&P500.

Emera Incorporated is an energy and services firm that owns and invests in electricity generation, transmission and distribution, gas transmission, utility services, energy marketing and trading services, and other energy-related management services. The company has a market cap of $7.04 billion. The Firm provides regional energy solutions by connecting its assets, markets and partners, primarily in eastern Canada, the northeastern United States, and the Caribbean. It has 17.64 P/E ratio.

The post Hearing on Emera Acquisition Of TECO Energy Moved Earlier (TSE:EMA) appeared first on Sonoran Weekly Review.

The stock is down 7.48% or $3.57 after the news, hitting $44.15 per share. About 1.16M shares traded hands. bluebird bio Inc (NASDAQ:BLUE) has declined 63.32% since September 14, 2015 and is downtrending. It has underperformed by 70.89% the S&P500.

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its product candidates include Lenti-D, which is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell disease (SCD) in France, as well as a phase I study in the United States for the treatment of severe SCD. The companyÂ’s lead chimeric antigen receptor T cell-based product candidate is bb2121, which is in phase I clinical trials for the treatment of relapsed and refractory multiple myeloma. bluebird bio, Inc. has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology; and Kite Pharma, Inc. to develop and commercialize second generation T cell receptor product candidates against the human papillomavirus type 16 E6 oncoprotein. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.

The post bluebird bio Shares Jump 7% Pre-Bell Ahead of Presentation of Positive Lenti-D Data (NASDAQ:BLUE) appeared first on Sonoran Weekly Review.

The stock is 0.00% or $0 after the news, hitting $4.3 per share. It is down 51.19% since September 14, 2015 and is downtrending. It has underperformed by 58.76% the S&P500.

Black Diamond Group Limited is a provider of remote workforce accommodations, modular space solutions and oilfield services and products in Canada, the United States and Australia. The company has a market cap of $182.25 million. The Firm provides its services and products to a range of industries, including oil, natural gas, mining, power, construction, engineering, military, Government and education. It has 21.03 P/E ratio. It operates in four divisions: Black Diamond Structures, Black Diamond Logistics, Black Diamond Energy Services and Black Diamond International.

The post Black Diamond Provides Segmented Historical Financial and Operational Data Following Reorganization (TSE:BDI) appeared first on Sonoran Weekly Review.

The stock is down 0.38% or $0.08 after the news, hitting $20.88 per share. About 112,437 shares traded hands. Northland Power Inc. (TSE:NPI) has risen 31.00% since September 14, 2015 and is uptrending. It has outperformed by 23.43% the S&P500.

Northland Power Inc. is an independent power producer. The company has a market cap of $3.54 billion. The Firm is engaged in developing, building, owning and operating facilities in Canada, Europe and other selected jurisdictions that produce electricity from clean-burning natural gas and renewable resources , such as wind, solar and biomass. It currently has negative earnings. Northland operates through five divisions: thermal, renewable, managed, which includes management and activities services for Kirkland Lake, Cochrane and Canadian Environmental Energy Corporation (CEEC); offshore wind, including Gemini and Nordsee, and other, which includes investment income and wood-chipping operations, as well as the administration of Northland.

The post Ontario Court of Appeal Sides with Northland Power in Power Purchase Agreement Payments Case (TSE:NPI) appeared first on Sonoran Weekly Review.

Baxter International (NYSE:BAX) said pre-market Wednesday it received marketing authorization in the U.K. and Denmark for NUMETA G13E, a intravenous nutrition product for preterm newborns. The product is indicated for neonates when oral or enteral nutrition is impossible, insufficient or contraindicated. The provider of renal and hospital products said it is also seeking approval in 18 other European countries for NUMETA G13E. ”Baxter has developed a well-balanced solution to help meet the nutritional needs of these patients in the hospital with a triple-chamber system that simplifies the preparation process for healthcare workers and reduces the risk to patients of infection and dosing errors,” said Baxter’s senior medical director Mark DeLegge. Shares were inactive in recent pre-market. The stock hit a new lifetime high on Tuesday and has a new 52-week range of $32.18 to $43.50.

The stock is up 0.12% or $0.05 after the news, hitting $43.42 per share. About 1.50M shares traded hands. Baxter International Inc (NYSE:BAX) has risen 20.57% since September 14, 2015 and is uptrending. It has outperformed by 13.01% the S&P500.

Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis (HD), home HD, continuous renal replacement therapy, and additional dialysis services. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products.

This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctorsÂ’ offices, and by patients at home under physician supervision. Baxter International Inc. offers its products through direct sales force, independent distributors or sales agents, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

The post Baxter International Gets Marketing Approval in UK & Denmark on Ready-to-Use Nutrition for Newborns (NYSE:BAX) appeared first on Sonoran Weekly Review.

The stock is up 0.69% or $0.05 after the news, hitting $7.25 per share. About 11,991 shares traded hands. Ooma Inc (NYSE:OOMA) has declined 17.43% since September 14, 2015 and is downtrending. It has underperformed by 25.00% the S&P500.

Ooma, Inc. provides communications solutions and other connected services to small business, and home and mobile users in the United States and Canadian markets. The company offers Ooma Office Mobile HD app that allows users to remotely access their business communications system to make, receive, and transfer phone calls; Ooma Telo, a home communications solution designed to serve as the primary phone line in the home; and the Ooma Mobile HD app, which allows Ooma Telo users to make and receive phone calls and access Ooma features and settings with iOS or Android device over a Wi-Fi or cellular data connection. It also provides Ooma HD2 handset, a wireless handset with a color display that supports various enhanced Ooma features; Ooma Linx, a remote phone jack that allows the user to connect a phone, fax machine, and alarm panel; Ooma Safety Phone, a wireless hands-free speakerphone that can be worn as a pendant; and Ooma Wireless + Bluetooth adapter that adds Wi-Fi and Bluetooth capability to Ooma Telo, as well as Ooma Headset, a noise-canceling headset. The company offers its products through direct sales, retailers, and online, as well as through retail and reseller partnership channels. Ooma, Inc. was incorporated in 2003 and is headquartered in Palo Alto, California.

The post Ooma Receives Four U.S. Patents for Communications Systems; Shares Unchanged in Pre Market (NYSE:OOMA) appeared first on Sonoran Weekly Review.

The stock is up 1.15% or $0.19 after the news, hitting $16.76 per share. About 964 shares traded hands. Applied Genetic Technologies Corp (NASDAQ:AGTC) has risen 14.83% since September 14, 2015 and is uptrending. It has outperformed by 7.26% the S&P500.

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products to treat patients with severe inherited orphan diseases in ophthalmology in the United States. The companyÂ’s lead product candidates include treatments for X-linked retinoschisis, achromatopsia, and X-linked retinitis pigmentosa, which are inherited orphan diseases of the eye caused by mutations in single genes.

It is also developing adeno-associated virus based gene therapies for the treatment of rare eye diseases; and a product candidate for treatment of alpha-1 antitrypsin deficiency for which it has conducted preclinical proof-of-concept studies and Phase I and Phase II clinical trials. In addition, the company is involved in the pre-clinical development of treatments for wet age-related macular degeneration. Applied Genetic Technologies Corporation has collaboration agreements with Biogen; and 4D Molecular Therapeutics. The company was founded in 1999 and is headquartered in Alachua, Florida.

The post Applied Genetic Technologies Reports Encouraging Data on Eye Disorder Treatment; Shares Flat Early (NASDAQ:AGTC) appeared first on Sonoran Weekly Review.

Boston Scientific (NYSE:BSX) Wednesday reported its has received European CE mark approval for a new subcutaneous implantable defibrillator system, as well as magnetic resonance conditional labeling for all previously implanted systems. The defibrillator systems are treatment options for patients at risk of sudden cardiac arrest, but that leave the heart and vasculature untouched, reducing the risk of complications associated with transvenous implantable cardioverter-defibrillators. The Boston Scientific defibrillator can be used in conjunction with magnetic resonance imaging (MRI). Boston Scientific said initial market release of the new defibrillator system has begun in a small number of European centers with a broad European launch scheduled for early this summer. Kenneth Stein, Boston Scientific chief medical officer, said, “These approvals give reassurance to physicians and their patients that they have access to any future MR scan needs, and underscores the Boston Scientific commitment to gain MR-conditional labeling on high-voltage devices that are being implanted today.” Boston Scientific said it is “actively pursuing” FDA approval of the defibrillator system as well as MR-conditional labeling for previously implanted systems.

The stock is up 0.05% or $0.01 after the news, hitting $19.68 per share. About 77,514 shares traded hands. Boston Scientific Corporation (NYSE:BSX) has risen 17.57% since September 14, 2015 and is uptrending. It has outperformed by 10.01% the S&P500.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems.

It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

The post Boston Scientific Reports European CE Mark Approval For Implantable Defibrillator (NYSE:BSX) appeared first on Sonoran Weekly Review.

The stock closed at $0.87 during the last session. It is down 33.85% since September 14, 2015 and is uptrending. It has outperformed by 26.28% the S&P500.

Taseko Mines Ltd. is a Canada-based mining company. The company has a market cap of $233.18 million. The Firm is engaged in acquiring, developing, and operating large tonnage mineral deposits. It currently has negative earnings. The Company’s asset is the 75% owned Gibraltar Mine, a copper/molybdenum mine located in central British Columbia.

The post Taseko Says Dissidents Disclose That Two Nominees Have Negligible Investment (TSE:TKO) appeared first on Sonoran Weekly Review.

The stock is down 2.32% or $3.48 after the news, hitting $146.35 per share. About 7,779 shares traded hands. Canadian Pacific Railway Limited (USA) (NYSE:CP) has risen 4.59% since September 14, 2015 and is uptrending. It has underperformed by 2.98% the S&P500.

Canadian Pacific Railway Limited, together with its subsidiaries, operates a transcontinental railway in Canada and the United States. It transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; and merchandise freight comprising finished vehicles and automotive parts, chemicals and plastics, crude oil, as well as petroleum, forest, industrial, metals, minerals, and consumer products.

The company also transports intermodal traffic consisting of retail goods in overseas containers that can be transported by train, ship, and truck, as well as in domestic containers and trailers that can be moved by train and truck. It offers rail and intermodal transportation services over a track network of approximately 12,500 miles, serving the business centers of Canada from Montreal, Quebec, to Vancouver, British Columbia, and the United States Midwest and Northeast regions. In addition, the company provides truck-rail transload facilities and logistics services. Canadian Pacific Railway Limited was founded in 1881 and is headquartered in Calgary, Canada.

The post Canadian Pacific Railway Plans to Launch New Share Repurchase Program and Increase Dividend by 43% (NYSE:CP) appeared first on Sonoran Weekly Review.

CR845 was triggered by a stopping criterion, based on elevated serum sodium levels, that was met during the first phase, according to a company statement early Wednesday. A subsequent review of safety data from the first 90 patients dosed was completed by Cara, the study’s Independent Data Monitoring Committee, and the FDA. The results of this safety data review confirmed that increases in serum sodium levels in CR845-treated patients beyond the normal range were dose-dependent. Based on this safety review and an analysis of efficacy trends, the study will continue as a three-arm trial testing two doses of CR845 versus placebo. Cara shares trade near the bottom end of their 52-week range of $4.26 – $23.61.

The stock is up 9.49% or $0.78 after the news, hitting $9 per share. About 26,679 shares traded hands. Cara Therapeutics Inc (NASDAQ:CARA) has declined 59.51% since September 14, 2015 and is downtrending. It has underperformed by 67.07% the S&P500.

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body’s peripheral nervous system. Its lead product candidate includes I.V.

CR845, which is in Phase III clinical trials for the treatment acute postoperative pain in adult patients, as well as completed Phase II clinical trials for the treatment of uremic pruritus disease. The company is also developing Oral CR845, which is in Phase IIa clinical trials for the treatment of moderate-to-severe acute and chronic pain; and CR701, which is in preclinical trial stage for treating neuropathic and inflammatory pain. It has licensing agreements with Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize products containing CR845 in South Korea; and Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing CR845 for acute pain and uremic pruritus in Japan. Cara Therapeutics, Inc. was founded in 2004 and is headquartered in Shelton, Connecticut.

The post Cara Therapeutics Reports FDA Removes Clinical Hold on Phase 3 Trial for Postoperative Pain Treatment (NASDAQ:CARA) appeared first on Sonoran Weekly Review.

The stock closed at $9.04 during the last session. It is down 39.97% since September 14, 2015 and is downtrending. It has underperformed by 47.54% the S&P500.

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor, which is in Phase IIb clinical trial for patients with heavily pretreated multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for relapsed/refractory multiple myeloma; Phase II/III clinical trial for patients with relapsed and/or refractory multiple myeloma; Phase II clinical study to treat acute myeloid leukemia; Phase IIb clinical trial for patients with diffuse large B-cell lymphoma; and Phase II/III clinical trial to treat liposarcoma. The company is also developing KPT-8602 that is in Phase I/II study for patients with relapsed/refractory multiple myeloma; KPT-9274, which is in Phase I clinical trial for patients with advanced solid malignancies or non-HodgkinÂ’s lymphoma; KPT-335 that is in Phase I clinical trial for the treatment of viral indications; and KPT-350, which is in preclinical stage to treat neurological disorders, and inflammatory and autoimmune diseases. Karyopharm Therapeutics Inc. was founded in 2008 and is headquartered in Newton, Massachusetts.

The post Karyopharm Therapeutics Reports Positive Data from Trial of KPT-350 to Treat Brain Injury; Shares Flat Pre Bell (NASDAQ:KPTI) appeared first on Sonoran Weekly Review.

The stock is up 3.05% or $0.09 after the news, hitting $3.04 per share. About 5,500 shares traded hands. Immunomedics, Inc. (NASDAQ:IMMU) has risen 30.53% since September 14, 2015 and is uptrending. It has outperformed by 22.96% the S&P500.

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. The company is developing Yttrium-90-labeled clivatuzumab tetraxetan, which is in Phase III registration study used for the treatment of pancreatic cancer. It is also developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAM5-SN-38 ADC that is in Phase II trials for the treatment of metastatic colorectal cancer; and epratuzumab, which is in two Phase III clinical trials for the treatment of systemic lupus erythematosus.

Its early-stage products include Veltuzumab, a humanized monoclonal antibody targeting CD20 receptors on B lymphocytes for the treatment of non-Hodgkin lymphoma (NHL) and autoimmune diseases; Milatuzumab, a humanized monoclonal antibody targeting tumors that expresses the CD74 antigen, which is in Phase 1 studies; Yttrium-90-Labeled Epratuzumab Tetraxetan, a radiolabeled anti-CD22 investigational product candidate for patients with NHL or acute lymphoblastic leukemia; and IMMU-114, a novel humanized antibody for the treatment of patients with B-cell cancers. The company also provides LeukoScan, a diagnostic imaging product for diagnostic imaging to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a collaboration agreement with Algeta ASA for the development of epratuzumab. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.

The post Immunomedics Gets US Patent For Immuno-Oncology Agents for Cancer Therapy (NASDAQ:IMMU) appeared first on Sonoran Weekly Review.

The stock closed at $10.01 during the last session. It is down 6.00% since March 21, 2016 and is uptrending. It has underperformed by 1.57% the S&P500.

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer’s disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.

The post Axsome Therapeutics Gets Pre-IND Guidance from FDA for AXS-05 for Agitation in Patients with Alzheimer’s Disease (NASDAQ:AXSM) appeared first on Sonoran Weekly Review.

Treatments for these diseases that improve kidney function, slow disease progression or avoid long-term corticosteroid use would meet a significant unmet medical need. Data from the trial are expected in the second half of this year or the first half of 2017. OMER trades in the lower half of the 52-week range between $8.90 and $30.23. It was inactive in recent pre-market trade.

The stock is up 4.69% or $0.64 after the news, hitting $14.29 per share. About 200 shares traded hands. Omeros Corporation (NASDAQ:OMER) has risen 3.41% since September 14, 2015 and is uptrending. It has underperformed by 4.16% the S&P500.

Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets OMIDRIA for use during cataract surgery or intraocular lens replacement. The companyÂ’s clinical products include OMS721 that is in Phase III clinical trials for the treatment of atypical hemolytic uremic syndrome; and in Phase II clinical trials for the treatment of thrombotic microangiopathies, IgA nephropathy, and other renal diseases.

Its clinical programs also comprise OMS824, which is in Phase II clinical trials for the treatment of schizophrenia and Huntington’s diseases; OMS405 that is in Phase II clinical trials for the treatment of opioid and nicotine addiction; and OMS201, which is in Phase I/II clinical trials for use during urological procedures. The companyÂ’s preclinical programs include OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson’s disease; OMS616 to control surgical and traumatic bleeding; and OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders. Its preclinical programs also comprise GPR17 for the treatment of demyelinating disorders; GPR101 for appetite and eating disorders; GPR151 for the treatment of neuropathic pain and cognition; GPR161 for triple-negative breast cancer treatment; GPR174 for dysfunction of regulatory T-cell modulation; GPR183 for the treatment of osteoporosis and EBV-related diseases; and GPCR and Antibody Platform for CNS, metabolic, CV, oncologic, musculoskeletal, and other disorders. In addition, the company is developing OMS103 that has completed Phase III clinical trials for arthroscopic anterior cruciate ligament reconstruction and arthroscopic partial meniscectomy. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington.

The post Omeros Starts Dosing Patients in OMS721 Phase 2 Program in Renal Diseases (NASDAQ:OMER) appeared first on Sonoran Weekly Review.

The stock is up 6.34% or $0.46 after the news, hitting $7.71 per share. About 388 shares traded hands. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has risen 9.68% since September 14, 2015 and is uptrending. It has outperformed by 2.12% the S&P500.

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-HodgkinÂ’s lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB for treating breast, gastric, colorectal, and lung cancers; EOQUIN for non-muscle invasive bladder cancer; and SPI-2012 for chemotherapy-induced neutropenia in patients with breast cancer.

The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.

The post Spectrum Pharma Gets Orphan Drug Status for Evomela – Shares up 6% in Light Pre-Bell Trade (NASDAQ:SPPI) appeared first on Sonoran Weekly Review.

The stock is up 39.78% or $0.37 after the news, hitting $1.3 per share. About 47,013 shares traded hands. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) has declined 18.42% since September 14, 2015 and is downtrending. It has underperformed by 25.99% the S&P500.

Oculus Innovative Sciences, Inc. designs, produces, and markets prescription and over-the-counter products based on its Microcyn platform technology for the dermatology, surgical, advanced tissue and skin care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. The Microcyn platform technology is based on electrically charged oxychlorine small molecules, which are designed to target a range of pathogens that cause disease, including viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human dermatology and advanced tissue care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand. The companyÂ’s Microcyn has received ten 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications.

In addition, it provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. Oculus Innovative Sciences, Inc. sells its products directly to third parties, and through contract sales organization and distributors to hospitals, physicians, nurses, and other healthcare practitioners, as well as to dermatologists for the treatment of various skin afflictions. Oculus Innovative Sciences, Inc. has a strategic collaborative agreement with the Lipogrid Company of Sweden to develop multiple topical drug delivery formulations. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is headquartered in Petaluma, California.

The post Oculus Innovative Sciences Shares Surge 50% Pre-Bell on FDA OK For Lasercyn (NASDAQ:OCLS) appeared first on Sonoran Weekly Review.

As a result, the company said it expects to file a Form 25 with the Securities and Exchange Commission on or around April 25 to effect the delisting of its common stock from Nasdaq as its shares would no longer be publicly-traded. Shares of ABCW and ONB were both inactive in recent after-hours. ABCW touched a new lifetime high and trades in a new 52-week range of $33.85 to $46.91. ONB closed at the midpoint of its 52-week range of $10.69 to $15.00.

The stock increased 0.58% or $0.27 during the last trading session, hitting $46.75. About 59,285 shares traded hands. Anchor BanCorp Wisconsin Inc (DE) (NASDAQ:ABCW) has risen 12.00% since September 11, 2015 and is uptrending. It has outperformed by 5.20% the S&P500.

Anchor BanCorp Wisconsin Inc. operates as the holding company for AnchorBank, fsb that provides retail and commercial banking services in Wisconsin. Its deposit products include passbook and statement savings accounts, non-interest bearing checking accounts, interest bearing checking accounts, money market deposit accounts, and certificates of deposit. The companyÂ’s loan products portfolio comprises residential loans; loans for commercial and business purposes, including letters of credit; commercial real estate loans, which comprise land and construction, multi-family, retail/office, and other commercial real estate loans; and consumer loans, such as express refinance loans, home equity loans, education loans, vehicle loans, and other secured and unsecured loans for various consumer purposes. It serves businesses and individuals through approximately 46 full-service branches. Anchor BanCorp Wisconsin Inc. was founded in 1919 and is headquartered in Madison, Wisconsin.

The post Anchor BanCorp Wisconsin to Delist From Nasdaq In Connection to Old National Bancorp Merger (NASDAQ:ABCW) appeared first on Sonoran Weekly Review.

KTE-C19 targets the CD19 antigen, a protein found on cell surface of B cell lymphomas and leukemias. In addition to producing ongoing complete responses in three of the early-stage patients, KTE-C19 also achieved rapid and durable responses in five patients with chemorefractory disease, including a complete response in four of those patients. “The data reported today are important because refractory DLBCL is incurable,” Doctors Ronald Levy, Robert Summy and Helen Summy of the lymphoma program at Stanford University School of Medicine said, adding that survival periods for those patients is typically is short and there is no standard therapy. “A rate of complete response and durability of response in the ranges reported today would be of profound clinical importance if replicated in the phase II portion of the ZUMA-1 study.” Kite currently is enrolling patients for a pair of Phase II trials along with two Phase I/II trials in either adult or pediatric patients with relapsed or refractory leukemia. The data was presented during the American Association of Cancer Research annual meeting at Washington University in St. Louis this week.

The stock is down 2.49% or $1.15 after the news, hitting $45 per share. About 1.00M shares traded hands. Kite Pharma Inc (NASDAQ:KITE) has declined 24.67% since September 11, 2015 and is downtrending. It has underperformed by 31.47% the S&P500.

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. The company is developing a pipeline of engineered autologous cell therapy-based product candidates for the treatment of solid and hematological malignancies. Its lead product candidate is KTE-C19, a chimeric antigen receptors (CAR)-based therapy that is in Phase 2 clinical trials for the treatment of patients with refractory diffuse large B cell lymphoma, including primary mediastinal B cell lymphoma and transformed follicular lymphoma.

The company is also conducting a Phase 2 clinical trial of KTE-C19 on patients with relapsed/refractory mantle cell lymphoma; a Phase 1-2 clinical trial of KTE-C19 on adult patients with relapsed/refractory acute lymphoblastic leukemia; and a Phase 1-2 clinical trial of KTE-C19 in pediatric patients with relapsed/refractory. In addition, it engages in developing T cell receptors-based therapies, which targets self-antigens, viral antigens, and neo-antigens. The company has a research collaboration and license agreement with Amgen Inc. to develop and commercialize various CAR-based product candidates; collaboration agreements with the Surgery Branch of the National Cancer Institute and bluebird bio, Inc.; cooperative research and development agreements with the U.S. Department of Health and Human Services; a license agreement with Cabaret Biotech Ltd.; a license and research agreement with Alpine Immune Sciences, Inc.; and a clinical trial collaboration agreement with Genentech to evaluate the safety and efficacy of KTE-C19, in combination with atezolizumab in patients with non-Hodgkin lymphoma. Kite Pharma, Inc. was founded in 2009 and is headquartered in Santa Monica, California.

The post Kite Pharma Reports Complete Response Rate During Phase I Testing of Drug Candidate in Lymphoma Patients (NASDAQ:KITE) appeared first on Sonoran Weekly Review.

The stock is up 0.39% or $0.07 after the news, hitting $16.6 per share. About 682,593 shares traded hands or 33.58% up from the average. Logitech International SA (USA) (NASDAQ:LOGI) has risen 13.10% since September 11, 2015 and is uptrending. It has outperformed by 6.30% the S&P500.

Logitech International S.A., through its subsidiaries, develops and markets hardware and software products that enable or enhance digital navigation, music and video entertainment, gaming, social networking, and audio and video communication over the Internet and home-entertainment control worldwide. The company operates through two segments, Peripherals and Video Conferencing. The Peripherals segment designs, manufactures, and markets various peripherals for personal computers (PCs), tablets, and other digital platforms. Its products include portable wireless Bluetooth speakers; gaming mice, keyboards, headsets, gamepads, and steering wheels; video products and other headset products that connect small and medium sized user groups; keyboards and covers for tablets and smartphones, as well as other accessories for mobile devices; pointing devices, such as PC-related mice, touchpads, and presenters; keyboards and keyboards/mice combos for various platforms; PC speakers, PC headsets, and in-ear headphones; PC-based Webcams; and remote control and home automation products.

This segment sells its products to a network of distributors, retailers, and original equipment manufacturers (OEMs). The Video Conferencing segment designs, manufactures, and markets various video conferencing products, infrastructure, and services for small and medium size enterprises, public sector, and other business markets. Its products comprise scalable high-definition (HD) video communication endpoints, HD video conferencing infrastructure software, and appliances to support large-scale video deployments, and services to support these products. This segment also offers SaaS video service. It markets its products to distributors, value-added resellers, OEMs, and direct enterprise customers. Logitech International S.A. was founded in 1981 and is based in Apples, Switzerland.

The post Logitech International S.A to Pay $7.5 Mln Penalty Due to Accounting Violations (NASDAQ:LOGI) appeared first on Sonoran Weekly Review.

Energy Transfer Equity, L.P (NYSE:ETE) is up 5% after Motley Fool reports that the company’s lawyers may not be able to issue an opinion on taxes, which could affect the company’s ability to close its merger deal with Williams Companies (WMB). Energy Transfer agreed last fall to buy Williams Companies for $8 per share in cash with the rest of the $43.50 merger consideration being paid via shares of a new company called Energy Transfer Corporation.

Because of the structure of the deal, Energy Transfer said then “the transaction is expected to be tax-free to Williams’ stockholders, except with respect to any cash received.” However, in a SEC filing, Energy Transfer Equity said it had yet to obtain a tax opinion for its proposed merger with Williams Companies from its tax lawyers. If the deal can not be done tax free, Williams Companies’ investors likely would balk because they could be on the hook for a big tax bill if the completion of the merger is deemed to be a taxable event. Williams disagrees and doesn’t think the deal will trigger any taxes for its investors. Both companies have reportedly been looking for a way out of the merger deal since the debt that has to be taken on to pay for the deal could sink the companies as oil prices decline.

The stock increased 4.57% or $0.45 during the last trading session, hitting $10.3. About 55.98 million shares traded hands or 171.88% up from the average. Energy Transfer Equity LP (NYSE:ETE) has declined 61.85% since September 11, 2015 and is downtrending. It has underperformed by 68.65% the S&P500.

Energy Transfer Equity, L.P. provides diversified energy-related services in the Unites States. It owns and operates approximately 7,500 miles of natural gas transportation pipelines and three natural gas storage facilities in Texas; and approximately 12,300 miles of interstate natural gas pipelines. The company sells natural gas to electric utilities, independent power plants, local distribution companies, industrial end-users, and other marketing companies.

Its midstream operations include ownership and operation of approximately 35,000 miles of in service natural gas pipelines, 31 natural gas processing plants, 21 natural gas treating facilities, and 4 natural gas conditioning facilities in Texas, New Mexico, West Virginia, Pennsylvania, and Louisiana; operation of natural gas gathering, oil pipeline, and oil stabilization facilities in South Texas, as well as a natural gas gathering system in Ohio; and transportation and supply of water to natural gas producers in Pennsylvania. The companyÂ’s natural gas liquid (NGL) transportation and services operations include ownership of approximately 2,000 miles of NGL pipelines, three NGL processing plants, four NGL and propane fractionation facilities, and NGL storage facilities. It also sells gasoline and middle distillates at retail; operates convenience stores primarily on the east coast and in the Midwest region of the United States; and gathers, purchases, stores, transports, markets, and sells crude oil, NGLs, and refined products. In addition, it provides natural gas compression services; treating services, such as carbon dioxide and hydrogen sulfide removal, natural gas cooling, dehydration, and British thermal unit management services; and manages coal and natural resources properties, as well as sells standing timber, leases coal-related infrastructure facilities, collects oil and gas royalties, and generates a total of 75 megawatts electrical power. The company was founded in 2002 and is based in Dallas, Texas.

The post Energy Transfer Equity, L.P Gains 5% on Possiblity Taxes Could Kill Merger Deal with Williams Cos (NYSE:ETE) appeared first on Sonoran Weekly Review.